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12 5 3The binding of ( I) o<bungarotoxin and ( H)(-)nicotine
to a membrane fraction of the supraoesophageal ganglion
from the locust Schistocerca gregaria was compared. For 
125( I) bungarotoxin binding a Kd and Bmax of 0.8 nM and
1.2 pmol/mg protein were calculated whereas the Kd and
Bmax for (3H )(-)nicotine binding were calculated to be 130
nM and 4 pmol/mg protein. A pharmacological profile for
these two binding sites was made. In the case of the 
12 5( I) o( bungarotoxin binding site, distinct cholinergic
pharmacology was evident consistent with this site being
part of an insect neuronal nicotinic acetylcholine
receptor. Dihydro j3 erythroidine, a classical nicotinic
antagonist, and two naturally occuring toxins,
methyllycaconitine and (+)anatoxin-a, were found to be
particularly potent at this site. Furthermore, the 
12 5binding of ( I) C( bungarotoxin to this tissue shares 
pharmacological specificity with both vertebrate neuronal 
and peripheral nicotinic acetylcholine receptors. In 
contrast the ( H)(-)nicotine binding site appeared to be 
non-cholinergic in nature and the significance of this 
binding site is unclear. This ( H )(-)nicotine binding 
site did not bind the specific neuronal high affinity 
nicotine binding site ligand ( )methylcarbamylcholine.
vi
The o(bungarotoxin binding protein from locust ganglia was 
purified by affinity chromotography and on silver stained 
denaturing polyacr Xjlamide electrophoresis gel a 
predominant band at Mr 49,000 was consistently present in 
all the preparations made. This corresponds exactly to 
the Mr of a polypeptide in the ganglionic membrane 
fraction that is labelled by the nicotinic affinity ligand 
( H)MBTA and it is likely that these two polypeptides are 
identical.
Poly A+ mRNA extracted from locust ganglia was shown to 
direct the synthesis of the oC bungarotoxin binding 
component in Xenopus oocytes.
An antiserum was raised against a synthetic peptide, the 
sequence of which was derived from a clone isolated from a 
genomic DNA library of Schistocerca gregaria and 
corresponds to the 'cysteine loop' region present in all 
ion channel receptor protein subunits. This antiserum was 
shown to react with polypeptides of Mr 49,000 and 60,000 
in Western blots of the ganglionic membrane fraction. 
Moreover, the antiserum reacted with the purified 
cX bungarotoxin binding protein in Western blots. An 
antiserum raised against the purified (X bungarotoxin 
binding component recognised the synthetic peptide in a 
dot immunobinding assay. It is concluded that this 
genomic clone encodes a protein that is similar to that 
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1.1 Insects and the Pesticide Industry
Of the 1,200,000 identified species in the animal kingdom, 
97% are invertebrates. Moreover, 78% of the total 
identified species belong to the class Insecta. However, 
there is still a large number of insect species yet to be 
identified and the most accurate estimates suggest that 
there may be between four and five million individual 
species of insect on the earth's surface. Insects occur 
practically everywhere and have inhabited the earth for 
nearly 300 million years. As a result they have adapted 
to live in almost every kind of habitat available and have 
evolved to overcome the various problems of food supply 
and piotection against predetors.
The insects have always presented great problems to man. 
Not only are they responsible for transmission of many 
diseases but they are responsible for a great loss of 
agricultural produce. In fact it has been estimated that 
some 14% of the world's agricultural production is lost by 
insect attack each year and this figure does not include 
losses in pastoral farming or the loss of animal stock due 
to insect transmitted diseases (Cramer, 1967). Not all 
insects can be classified as pests and man has gained many 
benefits from the presence of insects, such as the 
pollination of crops and silk production.
3What then has man's approach to the problem of insect 
control been? In the 1930's there was widespread use of 
lead arsenate which was an effective insecticide but had 
the disadvantage that it was also poisonous to man. 
Nicotine has long been known to be a potent insecticide
(Friedlander, 1976), acting as a neuropoison, but again is 
just as poisonous to man and is unstable in air. Just
before the second world war a new insecticide was in use,
which was extremely toxic to insects but harmless to man. 
This compound was pyrethrum, an extract of the daisy 
Pyrethrum cinerariaefolium. However, the main supplies of 
pyrethrum came from Japan and Kenya and therefore these 
sources quickly dried up with the arrival of the war. 
There was a desperate need for a new widely acting 
insecticide. The discovery of para-dichloro diphenyl 
trichloroethane (DDT) filled this gap and marked the start 
of industrial insecticide development, mainly using the 
methods of random synthesis and screening. At present
there are four main classes of insecticide in use : the
organochlorides; the organophosphates? the carbamates? and 
the pyrethroids. However, the exact target at the 
molecular level for the majority of these insecticides is 
still largely unknown.
Many lessons have been learnt from the widescale use of 
insecticides. Two main factors responsible for the 
unforeseen problems encountered were the lack of pesticide
4specificity and the problem of resistance. The first of 
these has been noted in many situations where the 
parasites and predetors that normally hold the insect in 
check have proved to be more susceptible to the 
insecticides than the pest itself. The problem of 
resistance has been demonstrated most effectively in the 
control of the cotton weevil which in 1967 was resistant 
to all known insecticides of that time (Mathews, 1983).
There is now a major market for new, highly specific 
insecticides and the insecticide companies are now
starting to adopt more rational design approaches in 
addition to their synthesis and screen programmes.
Therefore, further research into basic neurobiology of 
insects is required before potential targets for
insecticides can be identified. At present, our knowledge 
of the insect nervous system is rather limited when 
compared to that of vertebrate species. However,
considerable progress is being made in our understanding 
of the cholinergic system in insects and the work detailed 
in this project is focused on the nicotinic acetylcholine 
receptor (nAChR) of the desert locust.
The full taxonomic classification of the desert locust, 
Schistocerca gregaria, is shown in figure 1. Locusts 
belong to the order Orthoptera which have the following
characteristics : the mouthparts are simple and suited for
5biting; the fore-wing is harder than the membranous hind- 
wing and in flight is not flapped but held out sideways
like an aeroplane’s wing; the hind legs are modified for
jumping; there are usually organs for sound production and 
reception.
1.2 The Insect Nervous Syste»
The insect central nervous system (CNS) is made up of a 
number of paired ganglia, lying along the length of the 
body, which are connected to each other longitudinally to 
form the ventral nerve cord (figure 2). In the embryonic
stage of the insect, each segment of the body contains its
own paired ganglion. Some of these ganglia fuse before 
the insect emerges from the egg and the degree of fusion 
depends on the individual species. Minimal degree of 
fusion is seen in species of the order Dictyopterus 
whereas the maximum degree of fusion is seen in species of 
the genus Musca. In the adult locust, there is a fused 
neural mass in the most anterior part of the head, the 
supraoesophageal ganglion, which is made up of one or more 
segmental ganglia along with the primitive pre-segmental 
archecerebrum. This ganglion is the centre for receiving 
all stimuli from the sense organs in the head as well as 
receiving excitatory impulses from the ventral nerve cord. 
It is therefore the major centre of association and to 
some extent controls the activity of the rest of the 
nervous system. It may also be involved in the process of
6learning and the regulation of long-term organised 
behaviour patterns. The supraoesophageal ganglion is 
composed of three main areas, the protocerebrum, the 
deutocerebrum and the tritocerebrum (figure 3). The
protocerebrum is continuous laterally with the optic lobes 
and is the most complex part of the brain. The
deutocerebrum is the point of origin of the antennal 
lobes. The circumoesophageal commissure connecting the 
supraoesophageal ganglion to the suboesophageal ganglion 
originates from the tritocerebrum and the tritocerebral 
lobes are connected by the frontal commissure. The
supraoesophageal ganglion is more complex than ganglia of 
the ventral nerve cord containing many neuropile regions.
1.3 The 'neurone doctrine'
In the middle of the 18th century there was much support 
for the theory that the brain was not composed of cells, 
but was a continuous network of vessels resembling the 
blood circulatory system. Long extensions originating 
from cell bodies were clearly visible in the observations 
of Deiter published in 1865. However, there was no 
evidence to suggest that these extensions had terminal 
ends completely surrounded by the cell membrane. In 1885 
the first piece of evidence in support of individual nerve 
cells was published by Golgi using a method of staining 
which identified only a few of the nerve cells present. 
There was little interest shown in this until 1888 when
7Ramon y Cajal modified Golgi's original staining method
and identified what appeared to be single cells in many 
brain regions. Acceptance of this proposal soon followed 
and in 1891 Waldeyer published a review of evidence 
supporting the existence of nerve cells calling them 
neurones and the nervous system became known as the 
"neurone doctrine". Final proof of individual nerve cells 
came from the use of the electron microscope in the
1950's, which showed that the nerve cell membrane, like 
the membrane of other cells, was continuous around each 
nerve cel1.
1.4 Cellular Structure of Insect Ganglia
All insect ganglia have a similar basic structure as shown
in figure 4. There is an outer layer, neural lamella, 
surrounding the ganglion beneath which lies a layer of 
cells called the perineurium. The nerve cell bodies
(perikarya) are found below the perineurium and are 
enveloped by one or more glial cells. In the centre of 
the ganglion is the neuropile region where all the
synaptic connections are found. There are no perikarya 
and little or no glial cells present in the neuropile 
region. In contrast to the vertebrate nervous system, 
there are no synapses onto the cell bodies of insect
neurones. Tracheoles are present in the ganglia although 
there is no vascular system and metabolites have to
diffuse from the haemolymph through the various layers of 
nervous tissue.
1.5 Synaptic Transmission
It was Ramon y Cajal who proposed the idea that nerve 
signals pass along dendrites and axons and that 
transmission between nerve cells occur only at points 
where the axons and dendrites come into contact. This was 
later confirmed by the electrophysiological studies of 
Sherrington (1925), who suggested that the point of 
contact between one nerve cell and another, or between a 
nerve and a muscle cell be called a synapse, a word 
meaning to clasp, connect or join. In 1904 Eliot's 
experiments suggested that an epinephrine-like substance 
was released from nerve terminals onto effector cells in 
the adrenal gland in response to electrical stimulation of 
the nerves. More definite evidence in support of chemical 
transmission came from the experiments of Loewi (1921), 
who demonstrated that chronic stimulation of the vagus 
nerve resulted in the release of a chemical 
(acetylcholine) into the bathing medium and that this 
medium could then mimic vagal stimulation. Conclusive 
proof of synaptic transmission came from the 
identification of nerve terminals and synaptic vesicles, 
again using the electron microscope.
1.6 Cholinergic Transnission
1.6.1 The history of acetylcholine
Acetylcholine (ACh) was the first neurotransmitter to be 
identified and the study of cholinergic transmission can
9be traced back to the middle of the 19th century, when 
Bernard carried out some experiments in which he
demonstrated that skeletal muscle contraction in response 
to nerve stimulation could be blocked by the application 
of curare. This was followed by Langley (1905) who 
demonstrated that the application of nicotine to skeletal 
muscle resulted in contraction which could be prevented by
curare, and he was the first to propose the presence of
receptor molecules which he called "receptive substances". 
In 1914, Dale identified two types of cholinergic 
activity, muscarinic and nicotinic, in the nervous system 
based on the effects of nicotine and muscarine. Dale then 
proceeded to provide evidence that ACh acts as a 
neurotransmitter in autonomic ganglia and at the 
neuromuscular junction.
1.6.2 The cholinergic synapse
Considerable knowledge of the structure and events at the 
cholinergic synapse is now known, and is summarised in 
Figure 5. ACh is synthesised from AcetylCoA and choline
by the enzyme choline acetyltransferase (ChAT). Newly 
synthesised ACh is stored in synaptic vesicles. An action 
potential arriving at the synapse leads to the 
depolarisation of the nerve terminal. This in turn allows 
an influx of Ca++ ions which are required for the release 
of ACh from the synaptic vesicles into the synaptic cleft. 
The released ACh then crosses the cleft and binds
10
reversibly to a receptor protein situated in the post- 
synaptic membrane. The result of this binding is a 
cellular response. In the case of nAChR's, the response 
is an increase in conductance of Na+ ions. Under non-
physiological conditions, other cations such as K+ and
"H" •  •Ca will also pass through the nAChR channel. A variety
of responses are linked to muscarinic acetylcholine
receptors (mAChR's) including an increase in the
concentration of cGMP, a decrease in cAMP and the
breakdown of polyphosphoinositides. These three responses
are thought to be responsible for changes in K+ ion
permeability and may occur sequentially or independently.
Released ACh may also act at presynaptic autoreceptors.
The nicotinic autoreceptor is thought to increase ACh
release (Moss and Wonnacott, 1985) whereas the muscarinic
autoreceptor may have a negative feedback effect
terminating synaptic release of ACh (Polak, 1971?
Nordstrom and Bartfai, 1980). The ACh in the synaptic
cleft is prevented from accumulating by the action of
acetylcholine esterase (AChE), a membrane bound enzyme
which hydrolyses ACh to acetate and choline. Free choline
is then taken back into the presynaptic terminal by a high
affinity choline carrier and can be reincorporated into
ACh.
1.6.3 The insect cholinergic synapse
Most of the cholinergic elements described in the previous 
section have been identified in insect nervous tissue. 
Very high activities of ChAT have been detected in the
11
nervous system of the moth Manduca sexta (Prescott e t . 
a l . , 1977), antibodies have been used to localise this
enzyme in the CNS of the fruitfly (Drosophi la 
melanogaster) (Buchner et. a l ., 1986) and it has been
purified from ganglia of the locust Schistocerca gregaria 
(Lutz e t . a l . , 1988). ACh has been localised to the
neuropile region of insect ganglia (Colhoun, 1963). 
Moreover, synaptosomes prepared from Locusta migratoria 
ganglia (Breer, 1981b) have been shown to contain high 
quantities of ACh and synaptic vesicles have been isolated 
which contain ACh (Takeno e t . a l ., 1981). Synaptic
release of ACh in response to depolarising agents in a 
Ca++ dependent process has been demonstrated (Breer and 
Knipper, 1984) and choline has been shown to be taken up 
by a high affinity choline carrier into nerve endings 
(Breer, 1982). Post-synaptic depolarisations resulting 
from changes in membrane permeability in response to 
released ACh have been detected (Sattelle, 1980; Sattelle 
e t . a l ., 1980, 1983). Additionally, these responses can
be mimicked by locally applied acetylcholine (Callec, 
1974; Callec e t . a l ., 1982) and nicotinic agonists
(Sattelle, 1978) but are prevented by nicotinic 
antagonists (Sattelle, 1978; Sattelle e t . a l ., 1983).
Muscarinic cholinergic responses to released ACh are not 
well understood in insect tissue but are thought to be 
linked to 'changes in PI turnover (Trimmer and Berridge, 
1985; Duggan and Lunt, 1986) and changes in the 
concentration of cAMP (Duggan and Lunt, 1986).
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1.7 Vertebrate Nicotinic Acetylcholine Receptors
Nicotinic AChR's have been identified in both peripheral 
tissue (neuromuscular junction and electroplaque) and 
nueronal tissue (CNS and autonomic nervous system (ANS)). 
The peripheral nAChR is the most extensively characterised 
of all the neurotransmitter receptor proteins known. This 
is attributed to two main factors. Firstly, the use of 
the electric organ (electroplaque) from the electric fish 
Torpedo and the electric eel Electrophorus. This
specialised tissue is a very rich source of nAChR* s and 
most of the early work on this protein was performed using 
this tissue. The second important factor was the 
availability of the snake venom (Xneurotoxins from the 
Elapid snakes (Bungarus multicinctus and various species 
of Na ja) and in particular o(bungarotoxin which is an 
extremely potent antagonist, binding essentially 
irreversibly to the nAChR. In contrast our knowledge of 
neuronal nAChR*s is far less advanced and this in part may 
be due to the unsuitability of &  bungarotoxin as a probe 
for these receptors (see section 1.10.1) and the low 
abundance of these receptors in neuronal tissues.
1.8 The Torpedo nAChR
The characteristics of the Torpedo nAChR have been 
reviewed many times (Conti-Tronconi and Raftery, 1982; 
Changeux e t . a l ., 1984; Dolly and Barnard, 1984; McCarthy 
et. a l ., 1986). The protein has been affinity purified
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from detergent extracts using immobilised cxneurotoxins
(Raftery, 1973; Karlsson et. a l ., 1972) and has a relative
molecular weight (Mr) between 250,000 and 300,000
depending on the method of determination (Hucho, 1986). 
It consists of four types of subunit assigned CL, , ft' 
and S with Mr 40,000, 50,000, 60,000 and 65,000
respectively, which form a pentameric structure in the 
ratio . Small angle X-ray diffraction studies
have determined the overall shape of the pentameric 
protein in the membrane, shown in Figure 6. The nAChR 
from Torpedo is found predominantly as dimers in the 
membrane (Conti-Tronconi and Raftery, 1982), linked by a 
disulphide bridge between the 8 subunits. However the 
functional significance of this structure is unclear and 
the dimeric form is not observed in tissues from any other 
species (Hucho, 1986). A protein of Mr 43,000 is 
associated with the receptor and is thought to be a 
structural link between the nAChR and the cytoskeleton
(Porter and Froehner, 1985; Walker e t . a l ., 1984).
1.8.1 Primary structure of the subunits
The full coding sequences for each of the subunits of the 
Torpedo californica nAChR were determined from cDNA clones 
isolated with oligonucleotide probes (Noda e t . a l ., 1982, 
1983b, 1983c; Claudio e t . a l ., 1983) corresponding to the 
N-terminal sequence of each subunit which had been 
previously determined by protein sequencing (Devillers- 
Thiery et. a l ., 1979; Raftery e t . a l ., 1980). The
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OC subunit sequence of Torpedo marmorata has also been 
determined in this way and shows extensive homology to the 
Torpedo californica CX subunit (Devi 1lers-Thiery e t . a l .,
1983). Comparing the sequences of the subunits there is 
about 40% homology with C>< being more homologous to than 
to ft or 8 and !f being more homologus to 8 than to cx or . 
This suggests that the four subunits have diverged from 
two and originally one ancestral gene (Raftery et . a l . , 
1980) .
1.8.2 Functional expression of cloned nAChR*s 
Functional expression of mRNA's for the four subunits 
derived from the cDNA clones has been achieved in the 
oocyte expression system (Mishina e t . al ., 1984) but not
in cell free translation systems. This can be attributed 
to the requirement for cellular functions and the presence 
of the cell membrane for correct post-translational 
modifications such as cleavage of leader sequences, 
glycosylation, methylation and acylation (Hucho, 1986). 
Site directed mutagenesis has established that the 
asparagine at position 141 ( 0( subunit sequence) is the
site of glycosylation and is important for receptor 
function (Mishina et. al., 1985).
1.8.3 Biochemical evidence for an integral ion channel 
Evidence in support of the presence of an integral ion
O O  x
channel came from Na flux and patch clamp experiments
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on reconstituted purified nAChR1s (Schiebler and Hucho, 
1978; Epstein and Racker, 1978; Schindler and Quast, 1980) 
and oocyte expressed nAChR's (Mishina e t . al ., 1984).
of the ion channel (Sakemann e t . a l ., 1985).
1.8.4 Tertiary structure of the nAChR
The exact tertiary structure of the individual subunits of 
the nAChR is still unknown since crystalisation of the 
protein followed by X-ray analysis has not yet been 
possible. Models of the tertiary structure of predicted 
secondary structures have been proposed based on the 
results from biochemical studies, electron microscopy and 
hydrophobicity analysis of the subunit sequences (Guy and 
Hucho, 1987) and these are shown in Figure 7. Four 
transmembrane regions (Ml, M2, M3 and M4) were identified 
from the amino acid sequence and both the N-terminal and 
the C-terminal were initially thought to be extracellular 
which led to the proposal of model 1 in Figure 7 (Noda e t .
a l ., 1982; Devi 1lers-Thiery et. a l . , 1983; Claudio e t .
a l ., 1983). However monoclonal antibodies have located
the C-terminal region to the cytoplasmic side of the 
membrane (Lindstrom e t . a 1., 1986) and since this requires 
five crossings of the membrane, a fifth transmembrane 
region (MA) was proposed, consisting of alternating polar
Hybrid expression studies using Torpedo CX, and ^
subunits and the S subunit of calf muscle receptor has 
indicated that the 6  subunit may be involved in the gating
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and hydrophobic residues, which was thought to form the 
ion channel, leading to the proposal of model 2 in Figure 
7 (Guy, 1984; Finer-Moore and Stroud, 1984). Mutagenesis 
experiments have implicated that the region connecting MA 
to M4 may be associated with the agonist binding site and 
therefore on the extracellular side thereby lending 
support to model 2 (Mishina e t . a l ., 1985). However, the 
regions MA and M4, and the portion of the polypeptide 
chain linking these segments, were shown to be on the 
cytoplasmic side of the membrane using monoclonal 
antibodies (Ratnam e t . a l ., 1986a, 1986b) and this has led 
to the proposal of a third model of the tertiary structure 
(model 3 Figure 7) where the MA and M4 regions ardoca ted 
intracellularly (Ratnam et. a l ., 1986a). In contrast, the 
intracellular presence of the MA and M4 regions has also 
been explained by a non-functional conformation of model 2 
where the regions MA and M4 only span the membrane when 
the five subunits have aggregated (Finer-Moore and Stroud,
1984). Since all four types of subunit are highly 
homologous to each other it is believed that they will all 
have the same tertiary structure. In model 3 the 
transmembrane region M6 is proposed to form the ion 
channel whereas in model 2 it is the MA region that is 
thought to form the ion channel. However, recent 
experiments using triphenylmethylphosphonium (TPMP), a 
channel blocker, suggest that M2 is involved in the 
formation of the ion channel (Giraudat e t . a l ., 1986;
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Hucho e t . a l ., 1986) perhaps in conjunction with MA (Guy
and Hucho, 1987).
1.8.5 Localisation of the ligand binding site 
The OCsubunit of the nAChR has been shown to contain the 
binding site for nicotinic agonists and competitive 
antagonists (for review see Hucho, 1986). However, one of 
the OC subunits in the pentamer has a higher affinity for 
d-tubocurarine than the other and the kinetics of 
OC bungarotoxin binding to the two OC subunits are
different. The affinity ligands 4 - (N-maleimido)
benzyltrimethylammonium iodide (MBTA) and
bromoacetylcholine (BACh) also bind preferentially to one 
of the OC subunits. Both of these affinity ligands label 
the sulphydryl groups in the ligand binding site and it 
has been demonstrated that MBTA labels the cysteine 
residues at positions 192 and 193 which are only present 
in the OCsubunit (Kao et . a l ., 1984). Using synthetic
peptides, the region 190-193 has been implicated as being 
involved in the binding of bungarotoxin (Lindstrom e t . 
a l ., 1986) although there are reports suggesting that
synthetic peptides corresponding to various other regions 
also bind OC bungarotoxin (Atassi e t . a l ., 1987). It seems 
likely that the ligand binding site is composed from 
various regions of the primary structure brought into 
close vicinity by the three dimensional structure of the 
protein, but includes the important adjacent cysteine 
residues at positions 192 and 193. The true three
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dimensional structure of the cholinergic binding site will 
probably be revealed by X-ray crystalography of the 
protein.
1.9 The Muscle nAChR
The vertebrate muscle nAChR has been characterised from 
many species and is similar to the electroplaque receptor 
with respect to structure and pharmacology. This is 
expected since electroplaque cells are derived from 
embryonic striated muscle cells. The amino acid sequence 
of each of the subunits of the receptor has been 
determined for chick muscle (Barnard e t . al ., 1986), mouse 
muscle (Heinemann et . a l ., 1986) and calf muscle (Noda e t . 
a l ., 1983a; Tanake e t . a l ., 1984; Takai e t . al ., 1984;
Kubo e t . al ., 1985; Takai e t . a l . , 1985). It is clear
that there is strong homology between these muscle nAChR 
subunits and the corresponding subunits of the 
electroplaque receptor (Kubo e t . a l ., 1985). However,
slight differences are observed for muscle receptors when 
compared to the Torpedo receptor. In the chick muscle 
receptor the ft subunit is thought to have a higher Mr than 
the ft subunit (Barnard et a l ., 1986). Also, an additional 
subunit has been identified in calf muscle, termed £  , 
which may replace the X  subunit during muscle development 
(Mishina et.a l ., 1986).
1.10 Vertebrate Neuronal nAChR*s
Both the CNS and ANS of vertebrates are known to contain 
nAChR's (Martin, 1986; Wonnacott, 1987). These receptors 
have been identified primarily by intracellular recording 
of depolarisations evoked by iontophoretically applied ACh 
and nicotinic agonists (Curtis and Crawford, 1969; Oswald 
and Freeman, 1981; Schuetze and Role, 1986). Ganglionic 
nAChR's can be blocked by hexamethonium, a C6 nicotinic 
antagonist, but not by decamethonium, a CIO nicotinic 
antagonist potent at the muscle receptor. There may be 
both C6 and CIO type nAChR's present in vertebrate CNS.
1.10.1 OlBunqarotoxin as a probe of neuronal nAChR*s 
There are conflicting reports on the ability of 
bungarotoxin to block synaptic transmission in both the 
CNS and ANS. In higher vertebrate species, o(bungarotoxin 
has been shown to be ineffective in blocking central 
(Duggan e t . a l ., 1976; Brown e t . a l ., 1983) and ganglionic 
(Brown and Fumigalli, 1977; Carbonetto et. a l ., 1978;
Ravdin and Berg, 1979; Kouvelas e t . a l ., 1978; Kato and
Narahashi, 1982) synaptic nAChR's. In contrast, 
OC bungarotoxin has been shown to block transmission in 
the ret ino-tectal synapses of the toad (Freeman, 1977; 
Freeman e t . a l ., 1980) and goldfish (Freeman et . al .,
1980; Schmidt and Freeman, 1980) and this receptor is 
thought to be located presynaptically (Henley et . a l ., 
1986; Langdon and Freeman, 1987). However, no inhibition
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of retino-tectal synaptic transmission by CXbungarotoxin 
in rat brain was observed (Schmidt and Freeman, 1980). 
Inhibition of synaptic transmission by cXbungarotoxin has 
also been demonstrated in frog sympathetic neurones 
(Marshall, 1981), the superchiasmatic nucleus of the rat 
hypothalamus (Zatz and Brownstein, 1981) and the rat 
inferior colliculus (Farley e t . a l ., 1983). Finally,
extrajunctional nAChR's have been shown to be present in 
the rat superior cervical ganglion which can be blocked by 
OL bungarotoxin (Dun and Karczmar, 1980) although the 
functional significance of extra junctional receptors is 
unclear.
1.10.2 Biochemical identification of neuronal nAChR*s 
Radiolabelled o(bungarotoxin, (-)nicotine and ACh have all 
been used to identify neuronal nAChR's (for review see 
Wonnacott, 1987). o(. Bungarotoxin binding sites showing
cholinergic pharmacology have been identified in both the 
CNS and ANS (Morley e t . a l ., 1979; Morley and Kemp, 1981? 
Oswald and Freeman, 1981; Schuetze and Role, 1986) 
although the functional significance of these sites is 
unclear. These sites are found mainly extrasynaptically 
and some are found on cells lacking any known cholinergic 
innervation. Nicotine and ACh appear to bind to identical 
sites whose distribution is different from that of 
OC bungarotoxin (Clarke et. a l . , 1985, 1986). High
affinity nicotine binding sites in the CNS have been
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extensively characterised and show cholinergic 
pharmacology but are insensitive to (X bungarotoxin 
(Wonnacott, 1987). Therefore, there appear to be at least 
two distinct types of nAChR in vertebrate brain, based on 
the ability to bind (Xbungarotoxin. More recently, a new 
radioligand ( H)methylcarbamylcholine (MCC) has been shown 
to be a specific ligand for the neuronal high affinity 
nicotine binding site (Abood and Grassi, 1986; Boksa and 
Quirion, 1987) and these sites have been localised by 
autoradiography with this ligand (Yamada et . a l ., 1987).
1.10.3 Other naturally occuring toxins as probes of 
neuronal nAChR1s 
Another toxin sometimes present in commercially available 
OC bungarotoxin samples has been isolated (kappa 
bungarotoxin, also called toxin 3.1 and toxin F) which is 
able to block synaptic transmission in the chick ciliary 
ganglion (Chiapinelli, 1985). This toxin has a Mr of
6,500 on denaturing gel electrophoresis and shows homology 
of about 47% with (X bungarotoxin. Kappa bungarotoxin 
binds to two sites in the chick ciliary ganglia one of 
which is the (Xbungarotoxin binding site and the other may 
be a high affinity nicotine binding site. More recently,
(+ )anatoxin-a, a product of the fresh water alga Anabaena 
flos-aquae, has been shown to be an extremely potent 
inhibitor of ( H )(-)nicotine binding in rat brain with a 
lower affinity for the rat brain (Xbungarotoxin binding
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site (MacALLan et . al., 1988) and was shown to be a potent
agonist of a nAChR in cultures of rat hippocampal cells
(Aracava et. al . , 1987 ). This toxin has previously been
demonstrated to be a potent agonist at the vertebrate
neuromuscular junction closely resembling acetylcholine in
its channel properties (Albuguerque and Spivak, 1984;
Swanson et. a l ., 1986). Methyllycaconitine (MLA), a
component found in the seeds of Delphinium browni, is a
potent insecticide (Jennings et. a l ., 1986) but is only
moderately effective as an antagonist at the mammalian
neuromuscular junction (Nambi-Aiyar et. al ., 1979). This
toxin has also been shown to be an effective inhibitor of 
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1.10.4 Purification and characterisation of neuronal 
nAChR1s
Using the techniques developed for the electroplaque 
nAChR, o( bungarotoxin binding sites have been purified 
from neuronal tissue of rat (Wonnacott e t . al ., 1982; Kemp 
et. al ♦ , 1985), mouse (Seto et. al. , 1981), goldfish
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(Oswald and Freeman, 1979), chick optic lobe and chick 
brain (Norman et. al . , 1982; Conti-Tronconi e t . a l .,
1985). These proteins have been shown to be labelled by 
the affinity ligands MBTA and BACh (Lukas and Bennett, 
1980). The (X bungarotoxin binding component from chick 
brain was initially found to have only one subunit of Mr
54.000 (Norman e t . a l ., 1982) but was subsequently shown
to consist of three subunits of Mr 48,000, 56,000 and
69.000 (Conti-Tronconi e t . a l ., 1985), with the 56,000
subunit being labelled with BACh. Additionally,
monoclonal antibodies directed against the chick muscle 
nAChR were shown to cross react with this chick brain 
C<bungarotoxin binding component (Mehraban e t . a l ., 1984).
The purified rat brain oibungarotoxin binding component 
was found to consist of three subunits of Mr 49,000,
53,500 and 55,000 and it was the 55,000 subunit that was 
labelled with MBTA (Kemp e t . a l ., 1985). This
OC bungarotoxin binding component of rat brain has been 
separated from the high affinity nicotine binding site 
using an 0( bungarotoxin affinity column (Wonnacott, 1986) 
and this provides further evidence that these two binding 
sites are separate entities.
Rapid progress is now being made on the purification of 
the high affinity nicotine binding site which is 
insensitive to OCbungarotoxin. Using a monoclonal 
antibody (Mab 35) against the Torpedo nAChR, a protein
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complex consisting of two types of subunit with Mr 49,000 
and 59,000 has been purified from chick brain (Whiting and 
Lindstrom, 1986a). This protein was labelled with BACh 
which could be blocked by carbachol but not by OC 
bungarotoxin (Whiting and Lindstrom, 1986a). The same 
protein could bind ( H ) (— )nicotine with high affinity 
which could be blocked by various nicotinic cholinergic 
ligands but not by (Xbungarotoxin (Whiting and Lindstrom, 
1986b) and it was the 59,000 subunit of this protein 
complex that was labelled with MBTA (Whiting and 
Lindstrom, 1987a). A second nAChR has been identified in 
chick brain, using a monoclonal antibody (Mab 270) against 
the previously purified chick brain nAChR, which has been 
shown to consist of a protein complex of subunits with Mr
49,000 and 75,000 (Whiting e t . a l ., 1987a). This antibody 
has further been used to purify the rat brain high 
affinity nicotine binding site (Whiting and Lindstrom, 
1987b) which consists of two subunits with Mr 51,000 and
79,000. Mab 270 has also been used to localise nAChR's in 
rat and mouse CNS and the pattern of distribution was 
found to be similar to the distribution of ( H ) (-)nicotine 
binding sites in these tissues (Swanson et. al., 1987).
Functional nAChR's have been identified on PC12 cells 
using Mab 270 (Whiting et. a l ., 1987c) which are distinct 
from the <X bungarotoxin binding sites also present on 
these cells. More recently, monoclonal antibodies against 
the rat brain nAChR have been used to study bovine and
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human neuronal nAChR's (Whiting and Lindstrom, 1988). The 
immunoaffinity purified bovine nAChR consists of two 
subunits with Mr 50,600 and 74,400 and is therefore very 
similar to rat and chick brain nAChR's. A nAChR has also 
been purified from rat brain using an affinity column made 
with (-)-6-hydroxymethyl-nicotine and this purified 
protein has been characterised with idiotypic and anti- 
idiotypic antibodies to nicotine (Abood et. a l ., 1987).
This protein complex consists of two subunit types with Mr
57,000 and 62,000 and is therefore different from the 
protein purified by Whiting and Lindstrom (1987b).
1.10.5 Molecular cloning of neuronal nAChR's 
Using cDNA probes of the muscle nAChR subunits, cDNA's 
coding for subunits of neuronal nAChR’s have been 
isolated. Three types of (X subunit have been identified 
in rat neuronal tissue, designated 0(2, 0(3 and (X4, but
tissue. The rat brain 0(2 gene was isolated from a rat 
brain cDNA library using the rat 0(4 clone as a probe 
(Wada et . a l ., 1988). The rat brain 0(3 gene was isolated 
from a cDNA library of PC12 cells using a mouse muscle 
o( subunit probe (Boulter et . a l ., 1986). The rat brain 
0(4 clone was isolated from cDNA libraries of rat 
hypothalamus and hippocampus using a mouse muscle 
o(subunit probe and the o( 3 probe (Goldman e t . al ., 1987).
subunit has been identified in this
The rat brain clone was isolated from a cDNA library
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of PC12 cells (Boulter et . al ., 1987). The three rat
brain c* clones are thought to code for agonist binding 
subunits whereas the rat brain jl 2 clone is thought to be 
a structural subunit. It now seems likely that the rat 
brain o( 4 clone encodes the rat brain 79,000 Mr subunit 
(Whiting e t . a l ., 1987b). Functional expression of j2 2
with 0(2 (Wada e t . a l ., 1988) and J2>2 with either ^ 3  or
0( 4 (Boulter e t . a l . , 1987) has been demonstrated in the
oocyte expression system. These expressed receptors are 
activated by ACh and nicotine but are insensitive to 
0( bungarotoxin. The receptors expressed by ot 3 and oC4 
in conjunction with yG 2 were shown to be blocked by toxin
3.1 whereas the receptor expressed by of 2 and 2 was 
insensitive to this toxin. Additionally, expression of 
o( 4 on its own also gave weak nicotinic response. More 
recently genes corresponding to o(2, 0(3, o(4 and ^ 2  of
rat brain have been isolated from the chick genome ( c< 2, 
oL 3, o(4 and non oL (n o( )) which show extensive homology
to the rat brain clones (Nef e t . a l ., 1988). Moreover,
the chick 0(4 and n o( mRNA's are very abundant in the 
cerebrum, optic lobe and cerebellum in the adult and in 
ovo (day 9-12) and this has allowed the isolation of full 
length cDNA clones for these genes. Messenger RNA's 
encoding the chick brain o(2 and 0(3 clones are not as 
abundant in avian brain tissue and cDNA's have not yet 
been obtained for these genes.
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1.11 Insect AChR's
Acetylcholine has long been known to be the major 
excitatory neuortransmitter in insect CNS (Colhoun, 1963; 
Pitman, 1971; Gerschenfeld, 1973; Kehoe and Marder, 1976). 
Three types of AChR have been identified in insect brain 
based on their pharmacological specificities (Sattelle, 
1980) and have been classified as mixed affinity AChR's, 
mAChR's and nAChR's.
1.11.1 The mixed AChR
The presence of AChR's with mixed muscarinic-nicotinic
pharmacology was demonstrated in soluble extracts of
housefly (Musca domestica) heads by the binding of the
cholinergic ligand ( H)muscarone (Eldefrawi and O'Brien,
1970; Eldefrawi eL. al ., 1970, 1971; Cattell and
Donnellan, 1972; Donnellan et. a l ., 1975; Mansour et . a l .,
1977). Both nicotinic and muscarinic ligands were shown
to inhibit this binding and therefore this site was
concluded to be an AChR with both muscarinic and nicotinic
properties. Other radiolabelled cholinergic ligands
(nicotine, decamethonium, dimethyl-d-tubocurarine and
atropine) were shown to bind to this same extract
(Eldefrawi e t . a l ., 1971), although o( bungarotoxin was
found to have no effect on the binding of 
3
( H)decamethonium (Mansour e t . a l ., 1977; Tripathi e t .
a l ., 1979). Various attempts were made to purify this
protein from the 100,000 x g supernatant (Jewess e t . a l .,
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1975; Mansour e t . al ., 1977; Tripathi e t « al ., 1979;
Harris e t . a l ., 1981) and the native Mr of the protein was 
calculated to be 320,000 - 380,000, consisting of two
types of subunit of Mr 83,000 and 91,000. Amino acid 
analysis of the protein revealed that it contained a high 
proportion of hydrophilic and polar residues suggesting 
that it may be a peripheral membrane protein (Harris e t . 
a l ., 1981). Both types of subunit were shown to be
glycoproteins with mannose, glucose and galactose being 
the major constituents (Donnellan and Harris, 1977; Harris 
e t . a l ., 1980). The functional significance of this
putative AChR is unclear and no further work has been
o
carried out since ( H)decamethonium ceased to be 
commercially available.
1.11.2 The insect mAChR
Muscarinic AChR's were shown to be present in membrane 
fractions of fruitfly heads (Dudai and Ben-Barack, 1977; 
Haim et . a l ., 1979), housefly heads (Jones and Sumikawa,
1981; Shakier and Eldefrawi, 1981), the supraoesophageal 
ganglion of Locusta migratoria (Breer, 1981) and 
Schistocerca gregaria (Aguilar and Lunt, 1984) and the 
cockroach (Periplaneta americana) ventral nerve cord
(Lummis and Sattelle, 1985) using the muscarinic
3 3antagonist ( H)quinuclidinyl benzilate (( H)QNB).
Solubilisation of this binding site has proved to be
difficult since the protein is particularly unstable
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losing binding activity with a half-life of 24 hours at 
4°C (Dudai, 1980). Triton X-100 was found to inactivate
the binding activity while 2M NaCl was found to release
only 20% of the total binding activity (Haim et. a l . , 
1979). More recently, Venter e t . al . (1984) affinity
labelled the mAChR in fruitfly heads with 
( H)propylbenzylcholine mustard and identified a 
polypeptide of Mr 80,000 which is in close agreement with 
the results of radiation inactivation studies which gave a 
Mr of 77,600 (Lummis et. a l . , 1984). Monoclonal
antibodies against rat brain mAChR's were shown to 
strongly crossreact with the fruitfly receptor (Venter e t . 
a l ., 1984) and it is becoming clear t/hat mAChR's are
highly conserved throughout diverse groups of organisms. 
A functional role for an insect imAChR has been
demonstrated at the neuromuscular junctiom on the extensor 
tibiae muscle of the metathoracic leg of Schi stocerca 
greqaria (Fulton and Usherwood, 1977; Fullton 1982).
1.11.3 The insect nAChR
The presence of o(bungarotoxin binding sites in insect CNS
125was first demonstrated by autoradiography of ( I) 
o(bungarotoxin binding to frozen sections of the fruitfly 
heads (Hall and Teng, 1975). Subsequently, 
bungarotoxin was shown to bind to the particulate fraction 
of fruitfly heads and not to the supernatant suggesting 
that this site was distinct from the mixed AChR (Schmidt-
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Nielsen e t . al . , 1977; Dudai, 1977, 1978; Rudloff, 1980;
Jiminez and Rudloff, 1980). Binding sites for o( 
bungarotoxin have also been identified in housefly head 
homogenates (Eldefrawi and Eldefrawi, 1980; Harris e t . 
a l ., 1979; Cattell et . a l ., 1980; Jones e t . a l ., 1981).
More recently, o( bungarotoxin binding sites have been
identified in locust ganglia (Filbin e t . a l ., 1983; Breer, 
1981a), cockroach CNS (Lummis and Sattelle, 1985) and 
honey bee heads (Sherby e t . a l ., 1986). The binding
characteristics for all these different tissues are very 
similar and are summarised in table 1. The binding of 
o( bungarotoxin shows no co-operativity indicated by a 
hill coefficient of 0.96 whereas that for acetylcholine 
was calculated to be 0.5 indicating either negative co- 
operativity or heterogeneity of sites (Dudai, 1980). The 
pharmacology of binding to these binding sites in 
different tissues is consistent with classical nAChR's in 
that the binding is inhibited by nicotinic ligands but not 
by muscarinic ligands (see for review Sattelle, 1980; 
Breer and Sattelle, 1987). It is interesting to note that 
decamethonium, the ligand used to identify the mixed 
affinity AChR, had no effect on the binding of
bungarotoxin to fruitfly head tissue (Schmidt-Nielsen e t .
a l ., 1977). Therefore it is clear that the insect CNS
does indeed contain high levels of o(bungarotoxin binding 
sites which show a pharmacological similarity to the 
vertebrate nAChR.
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1.11.4 Purification of the insect nAChR
Considerable effort has been made to purify the nAChR from 
insect tissue making use of the techniques developed for 
the vertebrate nAChR. This involves solubilising the 
component from the membrane with a detergent and purifying 
it on an affinity column usually made with o( bungarotoxin 
covalently linked to a gel support such as Sepharose. The 
oC bungarotoxin binding component has been solubilised 
from the membrane fraction of fruitfly heads and exhibits 
similar binding characteristics and pharmacological
specificities to that observed in the membrane bound form 
(Schmidt-Nielsen e t . a l ., 1977). However, Dudai (1978) 
reported difficulties in solubilising the fruitfly head 
0( bungarotoxin binding component with Triton X-100 and 
even in the presence of NaCl only partial release of the 
binding activity was observed. A more efficient
extraction from this tissue was achieved with deoxycholate 
at pH 9.0 (Jimenez and Rudloff, 1980). Moreover, a
purification scheme giving a 1200 fold purification of
the 0( bungarotoxin binding site from fruitfly heads was 
reported (Gepner, 1979; Hall, 1980), using a combination 
of Triton X-100 (1% W/V) and NaCl (0.1 M) followed by
affinity chromatography on an o( cobratoxin-Sepharose 4B 
affinity column. The pharmacology of binding to this
purified component was similar to that of the membrane
bound form and the estimated Mr of the receptor-toxin 
complex was 500,000 by gel filtration and 300,000 by
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sucrose density sedimentation, The (X bungarotox in binding 
site has been purified from housefly heads using affinity 
chromatography on an o( bungarotoxin affinity column and on 
denaturing gel electrophoresis consisted of subunits of Mr
42.000 and 25,000 with an intact Mr of 200,000 while the
42.000 subunit was found to label with MBTA (March e t . 
a l ., 1982). (X Bungarotoxin binding components have also
been purified from two species of locust. The protein 
purified by Filbin e t . a l . (1983) from Schi stocerca
gregaria was found to consist of polypeptides of Mr
60,000, 41,000 and 25,000 on denaturing gel
electrophoresis with a polypeptide of Mr 58,000 being 
labelled with MBTA. In contrast, the protein purified
from Locusta migratoria was found to consist of one major 
subunit type with a Mr of 65,000, although a minor 
component with Mr 58,000 was often observed and attributed 
to proteolysis (Breer e t . a l ., 1984). The intact protein 
was calculated to have a Mr of 250,000 - 300,000 by non­
denaturing polyacrylamide gel electrophoresis (Breer and 
Sattelle, 1987) and was therefore proposed to be a 
homooligomer made up from four or five of the 65,000 Mr 
subunits representing an evolutionarily primitive form of 
the nAChR. It was proposed that the gene coding for this
65,000 Mr subunit was an ancestral gene from which all 
other nAChR's have evolved (Breer et . a l ., 1985).
Affinity labelling of this putative nAChR has not been 
reported. More recently, the (X bungarotoxin binding
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component in cockroach CNS has been purified and was found 
to be identical to that of Locusta with one major subunit 
of 65,000 on denaturing gel electrophoresis (Sattelle and 
Breer, 1985). Therefore it is clear that there is no 
consistency in the results from different groups for the 
molecular composition of the insect nAChR with much work 
remaining to be done to clarify the status of this 
receptor.
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1.11.5 Distribution of ( I ) (X bungarotoxin binding sites 
To satisfy the criteria for identification of a specific 
binding component as a receptor it is necessary to examine 
the localisation of the binding site and correlate it with 
synaptic activity. The first demonstration of non- 
uniform distribution of (X bungarotoxin binding in the 
insect nervous system was shown by Hall and Teng (1975) in 
fruitfly with the binding being localised only to neuronal 
tissues. This binding was subsequently shown to be 
confined to synaptic areas of the neuropile and was absent 
from nerve tracts and cell bodies in the fruitfly CNS 
(Schmidt-Nielsen e t . a l ., 1977; Dudai and Amsterdam, 1977; 
Rudloff, 1978) and the binding within the neuropile region 
was of non-uniform distribution. This localisation of 
o(bungarotoxin binding to specific neuropile regions was 
also observed in the moth (Manduca sexta) with only a 
small level of binding being detected over non-synaptic 
regions of the CNS such as the non-synaptic neuropile, the
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cell body regions and the antennal nerves (Hildebrand e t . 
a l ., 1979). The 6th abdominal ganglion of the cockroach
has also been shown to bind OC bungarotoxin in the central 
neuropile region, although some binding was present in the 
periphery of the ganglion where glial cells and neuronal 
cell bodies are present (Sattelle et - a l . , 1981, 1983).
The pharmacology of this binding in all these studies was 
consistent with a nAChR. The binding of (Xbungarotoxin to 
fruitfly brain was blocked with unlabelled toxin and d- 
tubocurarine whereas atropine reduced but did not block 
completely the binding (Schmidt-Nielsen e t . a l ., 1977;
Rudloff, 1978). Nicotine was also found to block 
Ckbungarotoxin binding in autoradiographic studies (Dudai 
and Amsterdam, 1977). Similarly, the binding observed in 
the moth preparation was blocked by acetylcholine (in the 
presence of neostigmine) and d-tubocurarine but was only 
slightly reduced by QNB (Hildebrand e t . a l ., 1979).
Therefore, there is good evidence in support of the insect 
o( bungarotoxin binding component being a functional nAChR 
situated in a synaptic location. However, in contrast to 
this, there is evidence to suggest that oCbungarotoxin 
fails to block cholinergic transmission in insect CNS (see 
section 1.11.7).
1.11.6 Antibodies as probes of the insect nAChR 
Antibody studies are useful both in determining 
similarities between receptors from different species and
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in localising receptors in tissues. Monoclonal antibodies 
against the Torpedo marmorata nAChR have been shown to 
cross react with a protein in the neural membrane of the 
locust (Fels et . a l ., 1983). Two of these antibodies were 
directed against a region close to or at the ligand 
binding region of the nAChR since they could compete 
against o<bungarotoxin binding. Furthermore, the single 
subunit of Mr 65,000 purified from the locust ganglia was 
identified in a Western blot with one of these monoclonal 
antibodies (Breer et. a l ., 1985) thereby confirming the
cross-reactivity of the locust receptor with the Torpedo 
receptor. A monospecific antiserum raised against the 
nAChR purified from Locusta was used to identify receptors 
in the neuropile region of head and thoracic ganglia of 
the locust (Breer et . a l ., 1985) and the 6th adominal
ganglion of the cockroach (Sattelle, unpublished but see 
Breer and Sattelle, 1987). Monoclonal antibodies raised 
against the Torpedo californica nAChR, all specific for 
different epitopes, were shown to crossreact with fruitfly 
neural tissue identifying different regional subsets of 
receptor in axonal tracts, neuropile region, mechano- 
sensory bristle elements and photoreceptors (Chase e t . 
a l ., 1987). One of these antibodies has been used to
immunoprecipitate a protein which has a Mr of 51,000 on 
denaturing gel electrophoresis. An auto-anti-idiotypic 
acetylcholine antibody was used in an immunocytochemical 
localisation study in Locusta migratoria where specific
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immunoreactivity was identified in the neuropile areas of 
the protocerebrum, the optic lobes, the deutocerebrum, and 
the tritocerebrum of the supraoesophageal ganglion of 
Locusta migratoria (Vieillemaringe e t . a l ., 1987).
1.11.7 Evidence for functional insect nAChR1s 
It is necessary to back up radiolabelled binding studies 
with evidence that the binding site has a functional role 
in vivo. Most evidence for the insect oC bungarotoxin 
binding site representing a functional nAChR has come from 
electrophysiological studies on the cockroach 6th 
abdominal ganglion (for review see Breer and Sattelle, 
1987). This has been the tissue of choice due to the 
easily identifiable synapses of the cereal afferent and 
giant interneurone pathway. Iontophoretit, application of 
ACh onto the cell body and synaptic regions of the giant 
interneurone 2 resulted in membrane depolarisations 
(Callec, 1974? Callec e t . a l ., 1982? Harrow and Sattelle,
1983). Moreover, (X bungarotoxin was found to block 
synaptic transmission in the cereal afferent giant 
interneurone pathway (Sattelle e t . a l ., 1983). The time 
taken to achieve block was significantly greater when 
presynaptic release of acetylcholine was increased either 
by increased stimulation frequency or by the presence of 
4-aminopyridine, and when anticholinesterases were 
present. The concentration of o(bungarotoxin required to 
produce blockade of synaptic transmission was found to be
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close to its calculated Kd (Sattelle, 1986). The 
muscarinic antagonist QNB could not block synaptic 
transmission in this system confirming that the 
cholinergic response at this synapse is nicotinic in 
nature. The cell body of giant interneurone 2 also 
contains nAChR's as demonstrated by iontophoretic 
application of ACh onto the cell body which resulted in a 
depolarising response that could be blocked by 
DC bungarotoxin but not by QNB (Harrow and Sattelle, 
1983). Voltage clamp studies have yielded valuable 
information on the properties of the ion channel. The 
AChR of the fast coxal depressor motorneurone (Df) of the 
cockroach has been studied using this technique (Harrow 
et. al ., 1982) showing that this receptor gates a cation 
channel permeable to sodium, potassium and possibily 
calcium ions. Voltage clamp experiments have also 
revealed information on antagonist classification. For 
example, c< bungarotoxin causes a block of receptor 
function in a voltage independent manner (David and 
Sattelle, 1984) whereas histrionicotoxin (Sattelle and 
David, 1983), amantadine (Artola e t . a l ., 1982) and d-
tubocurarine (David and Sattelle, 1984) were shown to be 
voltage dependent blockers. The insecticide nereistoxin 
was shown to suppress acetylcholine induced currents in a 
voltage dependent manner (Sattelle e t . a l ., 1985). In
contrast, an CX bungarotoxin-insensitive nAChR has been 
identified on the dorsal unpaired median neurone cell body
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of the grasshopper (Schistocerca nitens) (Goodman and 
Spitzer, 1979) and in cockroach metathoracic ganglia 
(Sattelle e t . a l ., 1980) although the pharmacological 
specificity of these receptors has not yet been reported 
and their function is unclear.
More recently the technique of patch clamping has been 
applied to the study of insect nAChR's allowing detailed
analysis of the channel. A single class of inward channel
was identified on cell bodies of cockroach ganglia showing 
a single channel conductance of 40 pS and a reversal 
potential of 60 mV positive to resting potential (Sattelle 
et. a l ./ 1986). The purified nAChR of Locusta migratoria
was reconstituted into planar lipid bilayer membranes and 
single channel recordings of this reconstituted receptor 
gave a conductance of 70 - 80 pS (Hanke and Breer, 1986). 
Therefore, a functional role for insect neuronal nAChR's 
has been demonstrated in several insect species by a 
variety of techniques.
1.11.8 Cloning of insect nAChR*s
Following the work on vertebrate nAChR's, progress is now 
being made on the isolation of genes encoding insect
nAChR's. Functional expression of mRNA extracted from 
ganglia of Locusta has been achieved in the oocyte
expression system (Breer and Benke, 1985). Injection of 
increasing amounts of total mRNA resulted in an increase
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in the number of (Xbungarotox in binding* sites synthesised.
These binding sites were labelled duiring synthesis with 
35( SJmethionine, solubilised and precipitated with an 
antiserum prepared against the puirified nAChR from 
Locusta. On denaturing gel electrojphoresis a similar 
subunit pattern as for the purified nAChR was observed 
with this precipitated material (Breer: and Benke, 1986). 
Additionally, these receptors have been shown to be 
functional nAChR's by ion flux studies; (Breer and Benke,
1986). Hermans-Borgmeyer e t . a l ., (1986) have isolated
two overlapping cDNA clones (ARD) from a cDNA library of 
fruitfly heads using cDNA probes of the (X and ^ subunits 
of the Torpedo nAChR. The mature e?ncoded protein is 
predicted to consist of 497 amino acids and the sequence 
shows considerable homology to other niAChR subunits, and 
is thought to be a non OC subunit since it lacks the two 
adjacent cysteine residues corresponding* to 192 and 193 of 
the Torpedo receptor subunit. A similar clone was 
isolated from a genomic library of the locust 
(Schistocerca gregaria), using cDNA probes for the chick 
brain nAChR (Marshall e t . a l ., 1988a). This clone (non­
alpha) also has considerable homology^ to other nAChR 
subunits as well as to the ARD fruitfly clone. More 
recently, another insect nAChR subunit gene has been 
identified by screening a fruitfly genomic library with 
the chick CX2 probe (Bossy et . a l . , 19<88). Restriction
fragments containing exons of this gene were further used
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to probe Drosophila instar cDNA libraries resulting in the 
isolation of three overlapping cDNA clones coding for an 
alpha like subunit (ALS) of the nAChR. The expressed ALS- 
^3-galactosidase fusion protein failed to bind o(bungarotoxin 
and was therefore proposed to be similar to the vertebrate 
neuronal (X subunits. Additionally, this ALS clone, the 
locust non-alpha clone and the fruitfly ARD clone all
show greater homology to the vertebrate neuronal nAChR 
subunits than to the vertebrate neuromuscular 0( subunits.
1.12 Receptor Superfamilies
The full coding sequences of the two subunit types of the 
GABAa  receptor (Schofield et. a l . , 1987) and the
strychnine binding subunit of the glycine receptor
(Grenningloh e t . a l ., 1987) have recently been reported
and show extensive homology (about 50%) to each other and 
about 25% homology to each of the subunits of the Torpedo 
nAChR. Further, all these receptor subunits contain the 
same pattern of four transmembrane domains. It has been 
suggested, therefore, that there is a family of genes
coding for ligand gated ion channels which may have
evolved from an ancestral gene. This can be compared to
the second type of neurotransmitter receptor, those linked 
to second messenger systems, which also represents a
superfamily of receptors such as various adrenergic, 
muscarinic and opsin types (Dixon et. al ., 1986; Nathans
and Hogness, 1983). In the nAChR, a region of major
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interest is an extracellular y2 -st ructural loop which can 
be formed by the disulphide bonding of two conserved 
cysteine residues. This region shows very high homology 
in all the subunits of the Torpedo receptor as well as to 
the vertebrate neuronal subunits and the insect cDNA 
clones as shown in figure 8. The invariant proline 
residue in this sequence is predicted to form a ^  hairpin 
turn resulting in a yS structure with one face completely 
hydrophobic. This region is present in all ion channel 
receptors and it has been proposed to be part of the 
ligand binding site of the nAChR (Luyten, 1986).
1.13 The Aim of This Project
The true molecular structure of the insect nAChR is still 
largely unclear and controversial with different results 
emerging from the various groups of study. This project 
has attempted to define more clearly the pharmacological 
characteristics of the locust nAChR, to improve the 
purification of this protein, to make an immunological 
study of the locust nAChR and to provide information that 
may help in the cloning of insect nAChR genes. It seems 
likely that the true subunit structure of the insect nAChR 
will be elucidated by the techniques of molecular biology, 
although it will be essential to back up the cloning work 
with biochemical evidence. The results presented here are 




Adult locusts (Schistocerca gregaria) were purchased from
Cambridge Biosciences Services (Chesterton Hall Crescent,
Cambridge, UK) and Larujon Ltd. (Welsh Mountain Zoo,
3Colwyn Bay, Wales). (-)-(N-methyl- H)nicotine (78
125Ci/mmol) and ( l)Na were purchased from Amersham
International (Amersham, Bucks, UK). (N-methyl-
3 3
H)methylcarbamylcholine iodide (( H)MCC) (86.6 Ci/mmol)
was purchased from Du Pont (UK) Ltd. (NEN Research
Products, Wedgewood Way, Stevenage, U K ) . (+) and (-)
anatoxin-a were a gift from Dr H Rapaport (Dept, of
Chemistry, University of California, Berkley, USA) and MLA
was a gift from Dr M H Benn (Dept. of Chemistry,
University of Calgary, Alberta, Canada). (+)-Nicotine
d i (-)tartrate was provided by Dr R Barlow (Dept, of
Pharmacology, University of Bristol, Bristol, UK) and
dihydro j$ erythroidine (DH^ <3> E) was provided by Dr R G
Benfield (Merck Sharp & Dohme, Hoddesdon, Herts, UK). Mab
270, Mab 290 and Mab 299 were provided by Dr J Lindstrom
(Salk Institute, San Diego, U.S.A.). Amino acid
derivatives for the peptide synthesis were purchased from
Cambridge Research Biochemicals Ltd. (Button End, Harston,
UK). All other peptide synthesis reagents and 1,1-
Dimethyl-4-piperazinium (DMPP) were purchased from Aldrich
Chemical Co. Ltd. (Gillingham, Dorset, UK). HPLC grade
acetonitrile was purchased from BDH Ltd. (Broom Road,
Poole, Dorset, UK). HPLC grade water was purified on a
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Millipore Milli-Q reagent grade water system.
Nitrocellulose paper was purchased from Sartorius Ltd.
(Avenue Road, Belmont, Surrey, UK). Optiphase "safe" was
purchased from LKB Instruments Ltd. (Addington Road,
Selsdon, South Croydon, UK) . All other drugs and
chemicals were purchased from Sigma Chemical Co. (Poole,
Dorset, UK). Tritium was measured in either a LKB 1217
Rackbeta or a Packard Tricarb 4000 series liquid
125scintllation counter and I was measured in a LKB 1280 
ultrogamma counter.
2.2 Tissue Preparation
Two week old adult locusts were used for all experiments. 
Insects were anaesthetised with CC^# decapitated and the 
heads stored on ice. The cuticle was shaved off, from the 
mouth, through the eyes to the top of the head and the 
supraoesophageal ganglion removed to aluminium foil on
ice. For the binding experiments, as much of the eye 
material was removed as possible but in the case of the 
purification experiments the eye material was included. 




2.3,1 Preparation of a P2 Membrane Fraction From Locust 
Ganglia
The preparation of the P2 membrane fraction was 
essentially as previously described by Filbin et. a l . 
(1983). The fractionation scheme is shown in figure 9. 
Ganglia were homogenised in 50 mM potassium phosphate 
buffer, pH 7.4 (10 ml per 100 ganglia), containing 0.25 M 
sucrose, 1 mM EDTA, ImM EGTA and 0.01% (w/v) sodium azide 
at 4°C, using a Potter-Elvejham homogeniser with a motor 
driven pestle (speed, 500 rpm; 30 passes; radial 
clearance, 0.15 mm) The homogenate was filtered through 
nylon bolting cloth (159 yu m mesh) and the filtrate 
centrifuged at 500 x g for 10 minutes at 4°c in a Sorval
RC5B centrifuge with an SS34 rotor. The supernatant was
retained on ice and the pellet resuspended in the same 
buffer and recentrifuged. The combined supernatants were 
centrifuged at 100,000 x g for 30 minutes at 4°C in a 
Beckman L5-50B ultracentrifuge with a SW50.1 rotor. This 
pellet was termed the P2G pellet and was resuspended in 50
mM potassium phosphate buffer, pH 7.4, at a final ratio of
3 1256 ganglia per ml for the ( H)(-)nicotine and ( I)
OC bungarotoxin assays and 12 ganglia per ml for the
( H)MCC assay. For some experiments the P2G fraction was
washed in either 50 mM potassium phosphate buffer, pH 7.4,
or distilled water by resuspending in 30 ml and standing
at 4°C for 60 minutes. The membrane was then pelleted by
centrifugation at 100,000 x g as described above.
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2.3.2 Preparation of a P2 Membrane Fraction From Whole 
Heads
The whole heads were homogenised in a Sorval Omnimixer (3 
x 20 seconds# speed setting 5) at 4°C and the homogenate 
filtered through nylon mesh. The filtrate was further 
homogenised and fractionated exactly as described in 
section 2.3.1 with the exception that an S35 rotor 
replaced the SW50.1 rotor. The final pellet was termed 
the P2H pellet.
2.3.3 Preparation of a Detergent Extract From Locust 
Ganglia
Figure 10 shows the fractionation scheme for the 
preparation of the detergent extract. The ganglia were 
homogenised in 10 mM potassium phosphate buffer# pH 7.4# 
containing 0.25 M sucrose# 1 mM EDTA, ImM EGTA and 0.1% 
(w/v) sodium azide (10 ml per 100 ganglia)# as previously 
described (section 2.3.1). The homogenate was filtered 
through nylon mesh and the filtrate centrifuged at 45,000 
x g for 30 minutes at 4°C in a Sorval RC5B centrifuge with 
an SS34 rotor. The resulting pellet was resuspended in 10 
mM potassium phosphate buffer, pH 7.4# containing 1 mM 
EDTA, 1 mM EGTA# 3%(w/v) lubrol PX and 0.01%(w/v) sodium 
azide and incubated for 30 minutes at 20°C with constant 
mixing. The mixture was then centrifuged as before and 
the resulting supernatant was termed the detergent 
extract.
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2.4 Iodination of p(Bunqarotoxin
0( Bungarotoxin was iodinated to a specific activity of
around 700 Ci/mmol (depending on the batch), according to
the method of Urbaniak et . a l . (1973). (X Bungarotoxin
(2.5 nmol) in 20 ul of 50 mM potassium phosphate buffer,
125
pH 7.5, was mixed with 20 yu 1 of carrier-free Na I (100
mCi/ml) in dilute NaOH solution and 10 yiAl of 50 mM 
potassium phosphate buffer, pH 7.5. The reaction was 
started by the addition of 10 jx1 of 0.5% (w/v) chloramine- 
T in 50 mM potassium phosphate buffer, pH 7.5 and allowed 
to proceed for 1 minute at 20°C with constant stirring. 
The reaction was terminated by the addition of 750 of 
0.016% (w/v) sodium metabisulphite in 50 mM potassium
phosphate buffer, pH 7.5 and 2 0 0 of 1% (w/v) potassium
iodide in 50 mM potassium phosphate buffer, pH 7.5.
125 12 5( I) o( bungarotoxin was separated from free I by
passage down a Sephadex G25 column (25 cm x 1 cm)
equilibrated with 10 mM potassium phosphate buffer, pH
7.4, containing 1% (w/v) bovine serum albumin (BSA) and
eluted with the same buffer. Fractions (1 ml) were
collected and the radioactivity in 10 yi>.l aliquots was
determined. The peak fractions were pooled and the
125specific activity of the ( I) (X bungarotoxin was
calculated assuming 100% recovery of the protein. The 
toxin was stored at 4°C in elution buffer and was used for 
up to 4 weeks.
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2,5 Radioligand Binding Assays
3
2.5. 1____ Assay of ( H) (-)Nicotine Binding to the P2G
Fraction
3
Tissue samples (0.25 ml) were incubated with ( H )(— ) 
nicotine (50 nM unless otherwise stated) for 30 minutes at 
20°C, in the presence and absence (10 minute
_3
preincubation) of excess unlabelled (-)nicotine (10 M) to 
determine non-specific binding. In competition assays, 
tissue samples were preincubated with serial dilutions of 
the drug for 10 minutes at 20°C prior to addition of 
radioligand. It should be noted that preincubation may 
lead to desensitisation of the receptor. The samples were 
chilled on ice (60 minutes), diluted with 2 ml ice-cold 50 
mM potassium phosphate buffer, pH 7.4, and rapidly 
filtered under vacuum on Whatman GFC filters presoaked in 
0.3% (v/v) polyethyleneimine (PEI) (Bruns e t . a l ., 1983). 
The filters were washed twice with 2 ml of 50 mM potassium 
phosphate buffer, pH 7.4; filtration and washing was 
accomplished within 30 seconds. The filters were
transferred to scintillation vials, 5 ml of Optiphase 
"safe" scintillant was added and the radioactivity 
determined.
1252.5.2 Assay of ( I) (X Bungarotoxin Binding to the P2G 
Fraction
1 O C
The binding of( I) (^bungarotoxin to the P2G fraction 
was measured in essentially the same way as for ( H ) (— ) 
nicotine. Tissue samples (0.25 ml) were preincubated for
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10 minutes at 20°C in the presence and absence of excess
unlabelled c*bungarotoxin (10 ^M) or serial dilutions of
125competing ligand before addition of ( I) <X bungarotoxin 
(1 nM unless otherwise stated). Incubation was continued 
for 60 minutes at 20°C and the samples were filtered as 
for the ( H ) (-)nicotine assay.
3
2.5.3 Assay of ( H)MCC Binding to the P2G Fraction
3
The binding of ( H)MCC to the P2G fraction was determined
3
exactly as for ( H ) (-)nicotine binding (section 2.5.1.), 
with the exception that the membrane fraction contained 
twice the protein concentration.
1252.5.4 Assay of ( I) 0^  Bungarotoxin Binding of to the
P2H Fraction
Aliquots (100 yul) of the P2H fraction were incubated with
I O C
( I) 0< bungarotoxin (20 nM) for 60 minutes at 20°C. 
Incubation was terminated by addition of 1 ml of ice-cold 
50 mM potassium phosphate buffer, pH 7.4, and the samples 
were centrifuged at high speed in an MSE microcentaur.
The pellets were resuspended in 1 ml of ice-cold 50 mM
potassium phosphate buffer, pH 7.4, and recentrifuged. 
The pellets were then counted for radioactivity. Non­
specific binding was determined in the presence of an
excess of unlabelled (Xbungarotoxin (10~^M).
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1252.5.5 Assay of ( I) (X Bungarotoxin Binding to the 
Detergent Extract and the Purified oiBungarotoxin Binding 
Component
Aliquots (100 yu 1) were incubated, in the presence and
—6absence of an excess of unlabelled cXbungarotoxin (10 M ) , 
with (*^l) (X bungarotoxin (10 nM) at 20°C for 60 minutes. 
The samples were then filtered on Whatman GFB filters that 
had been presoaked in 0.3% (v/v) PEI. The filters were
washed with 5 ml of 10 mM potassium phosphate buffer, pH
7,4, containing 0.1% (w/v) Lubrol PX and counted for
radioactivi ty.
2.6 Affinity Purification of the oC Bungarotoxin Binding 
Component
2.6.1 Preparation of the o( Bungarotoxin-Sepharose 4B 
Affinity Gel
The affinity gel was prepared according to the method of 
March et. al. (1974). Sepharose 4B beads (25 ml packed
beads) were washed with 500 ml of 0.1 M NaCl followed by 
500 ml of distilled water. The beads were resuspended in 
50-100 ml of distilled water at 4°C and 100 ml of 2 M di­
sodium carbonate at 4°C was added. Cyanogen bromide 
(CNBr) in acetonitrile was added to a final concentration 
of 50 mg CNBr per ml of beads and stirred for 2 minutes at 
4°C. The beads were filtered rapidly and washed with 500 
ml of distilled water at 4°C over a period of 2-3 minutes.
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(X Bungarotoxin (2 mg) in 25 ml of 0.2M sodium hydrogen 
carbonate/ pH 9.4, was added to the activated Sepharose-4B 
and mixed at 4°C for 21 hours. The beads were then washed 
with 400 ml of distilled water (pH 9.0 with potassium 
hydroxide). 1M glycine (200 ml) was added to the beads 
and mixed for 2 hours at 20°C. The Sepharose 4B was 
washed with 150 ml of 0.1 M sodium acetate, pH 4.0, 
followed by 150 ml of 0.2 M sodium hydrogen carbonate, pH
9.4. This was repeated another twice and the affinity 
beads were finally resuspended and stored in 10 mM 
potassium phosphate buffer, pH 7.4, containing 0.002% 
(w/v) thimerosal as preservative and stored at 4°C.
2.6.2 Purification of the oCBungarotoxin Binding Component 
The detergent extract (section 2.3.3.) was mixed with 1-2 
ml (packed bed) of the CX bungarotoxin-sepharose 4B for 4- 
6 hours. The beads were then packed into a column 0.5 x 
10 cm. Non-bound material was washed out with two washes 
of 2 ml of 10 mM potassium phosphate buffer, pH 7.4, 
containing 0.5% (w/v) Lubrol PX and 1 M NaCl followed by 
20 ml of 10 mM potassium phosphate buffer, pH 7.4, 
containing 0.5% (w/v) Lubrol PX. Bound protein was eluted 
from the affinity column onto a DE52 ion exchange column 
by recycling 4 mM benzoquinonium chloride overnight 
(Lindstrom e t . a l ., 1981). The DE52 ion exchange column
was washed with 50 ml of 10 mM potassium phosphate buffer,
52
pH 7.4, containing 0.5% (w/v) Lubrol P X . Protein was
recovered from the DE 52 column by elution with 10 mM 
potassium phosphate buffer, pH 7.4, containing 0.5% (w/v) 
Lubrol PX and 1 M NaCl. Fractions were collected (0.25
1 c
ml) and assayed for the binding of ( I) o( bungarotoxin 
(see section 2.5.5).
2.7 Analysis of the Purified cX Bungarotoxin Binding 
Component
2.7.1 Precipitation of the (X Bung cxrotoxin Binding 
Component
The purified o( bungarotoxin binding component was
precipitated using a chloroform/methanol method (Wessel 
and Flugge 1984). Briefly, 4 parts methanol and 1 part 
chloroform were added to 1 part sample, followed by 3 
parts water. Phase separation was achieved by
centrifugation in a MSE microcentaur, and the upper phase 
was removed. Three parts methanol were added and the 
protein pelleted by centrifugation. The supernatant was 
removed and the pellet dried under a stream of nitrogen.
2.7.2 Sodium Dodecyl Sulphate Polyacrylamide Gel 
Electrophoresis (SDS-PAGE)
Electrophoresis was carried out under denaturing 
conditions according to the method of Laemli (1970). 
Pellets of the (X bungarotoxin binding component and the 
P2G fraction were resuspended in sample buffer (0.0625 M
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tris-HCl, pH 6.8, 2% (w/v) SDS# 5% (v/v) -
mercaptoethanol, 0.02% (w/v) bromophenol blue, 5% (v/v)
glycerol), boiled for 5 minutes and allowed to cool before 
being loaded onto the gel. Electrophoresis was performed 
in a Bio Rad Protean II system with a 10% running gel and 
5% stacking gel under constant current of 16 mA for the 
first 45 minutes and then 24 mA until the dye front was 
approximately 1 cm from the bottom.
2.7.3 Gel Protein Staining
2.7.3.1 Silver stain
Gels were stained using the method of Morrisey (1981). 
All solutions were made in double distilled water. The 
gel was fixed in 10% (w/v) trichloroacetic acid overnight 
at 20°C, followed by extensive washing at 20°C with 10%
(v/v) ethanol and 5% (v/v) acetic acid (3 x 30 minutes).
The gel was then incubated in oxidiser solution (0.0034 M 
potassium dichromate, 0.0032 N nitric acid) for 60 minutes 
at 20°C followed by 2 x 5 minute washes at 20°C with
double distilled water. The gel was then incubated with 
0.15% (w/v) silver nitrate at 20°C for 60 minutes in the 
dark, and washed once with double distilled water. 
Protein bands were developed with 3% (w/v) di-sodium
carbonate containing 0.0185% (v/v) formaldehyde at 42°C
until the required image developed. Development was 
terminated by transfer of the gel to 5% (v/v) acetic acid 
for 5 minutes. Gels were stored in double distilled
water.
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2.7.3.2 Coomassie blue stain
Gels were fixed and stained simultaneously with 0.25% 
(w/v) coomassie brilliant blue R250 in 45% (v/v) methanol 
and 9% (v/v) acetic acid overnight at 20°C. Destaining of 
the gel was achieved with 30% (v/v) ethanol and 10% (v/v) 
acetic acid. Gels were stored in 10% (v/v) acetic acid.
2.8 Affinity Labelling of the P2G Fraction
The P2G fraction was labelled with the affinity ligand 4- 
(N-maleimido)-benzoyltrimethylammonium iodide (MBTA) by 
the method of Barrantes et. al. (1975). Tritium labelled 
MBTA was synthesised by Dr R Harrison by the method of 
Karlin et. al. (1971) to a specific activity of 126 j^Ci/ 
mol. The P2G fraction was reduced by resuspending the 
pellet in 0.5 ml of 1 mM dithiothreiLol in 10 mM tris-HCl 
buffer, pH 7.3, containing 0.1 M NaCl and 1 mM EDTA, and 
incubated for 10 minutes at 20°C. The samples were 
centrifuged in a MSE microcentaur at high speed for 5 
minutes. The pellets were resuspended in 0.5 ml of 10 mM 
potassium phosphate buffer, pH 7.4, containing 0.15 M NaCl 
and 1 mM EDTA, and recentrifuged. The pellets were
_3
resuspended in the same buffer and (-) nicotine (10 M) 
was added to one of the samples, to determine non-specific 
binding, and incubated for 60 minutes at 20°C. (^H)MBTA 
was dissolved in 0.1 mM HC1 and 1 nmol was added to each 
sample and incubated for 3 minutes at 20°C. Excess 
13 mercaptoethanol (10 j*. 1) was added to stop the reaction 
and the samples immediately centrifuged. The pellets were
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washed once with 10 mM potassium phosphate buffer, pH 7.4, 
and finally resuspended in electrophoresis sample buffer. 
Electrophoresis was performed as detailed in section 
2.7.2. After electrophoresis the gel was stained with 
coomassie brilliant blue as detailed in section 2.7.3.2. 
Each track of the gel was then sliced (6 slices/cm) and 
the slices dried and solubilised in 500 yu 1 of 1% (v/v)
ammonium hydroxide in 30% (v/v) hydrogen peroxide.
Optiphase "safe" (5 ml) was added and the samples counted.
2.9 Peptide Synthesis
2.9.1. Chemical synthesis
The peptide was synthesised on a CRB Pepsynthesiser II 
controlled by an Olivetti M24 PC. Synthesis was based on 
the Fmoc-polyamide chemistry. This method uses
derivatised amino acids with a pentafluorophenyl (Pfp) 
group on the carboxyl group and a 9-fluoromethoxycarbonyl 
(Fmoc) protecting group on the amino group of the amino 
acid (Arshady et. a l ., 1981; Atherton et. a l ., 1981). The 
resin used was the pepsyn KA type (figure 11). The 
solvent used was N,N-dimethyl formide (DMF) which was 
distilled under reduced pressure prior to use and stored 
in a dark bottle for up to a week. This procedure removed 
any amines which would interfere with the synthesis. An 
outline of the synthesis procedure is shown in figure 12. 
The initial coupling step was carried out with 
recirculation for 4 hours in the presence of the catalyst
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4-dimethylaminopyridine. The Fmoc protecting group was 
not removed and the coupling procedure was repeated 
overnight to achieve maximum coverage of the resin. The 
Fmoc group was then removed with the base piperidine (20% 
(v/v) in DMF). Subsequent amino acids were added in the 
presence of 1-hydroxybenzotriazole and recirculation was 
for approximately 25 minutes. After recirculation, a 
small sample of the resin was taken and tested for free 
amino groups.
2.9.1.1 Kaiser colour test for the detection of free 
amino groups
A small sample of the resin was washed twice with DMF, 
twice with dichlororaethane (DCM), twice with ether and 
dried under a stream of nitrogen. To the beads, in a 
small tube, one drop each of 5% (v/v) ninhydrin in
ethanol, 400% (w/v) phenol in ethanol and 20 j* M  potassium 
cyanide in pyridine. The sample was heated for 5 minutes 
at 100°C. A blue colouration in the beads indicated 
incomplete coupling whereas a yellow colouration indicated 
complete coupling.
2.9.1.2 Colour test for the detection of free proline 
amino groups
A slight modification was introduced to the Kaiser test 
for the detection of free proline amino groups. The beads 
were washed as in the previous colour test and two drops
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of a saturated solution of istatin in benzyl alcohol 
containing 5% (w/v) Boc-Phe-OH was added. Two drops of
each of the Kaiser colour test solutions were added and 
incubated at 100°C for 5 minutes. The beads were then 
washed with acetone. Complete coupling was indicated by
white beads whereas a red/blue colouration indicated 
incomplete coupling.
2.9.1.3 Completion of the synthesis
After the final amino acid was added, the protecting group 
was removed. The resin was washed with 25 ml tertiary 
amyl alcohol (TAA), 25 ml glacial acetic acid, 25 ml TAA, 
25 ml DCM and 50 ml ether. The resin was then dried under 
a stream of nitrogen and the dried resin was stored at 
-20°C.
2.9.1.4 Cleavage of the peptide from the resin
The resin was incubated in a solution of 5% (v/v)
ethylmethylsulphide (EMS) in trifluoroacteic acid (TFA). 
EMS was included as a scavenger for the protection of 
methionine in the peptide. This solution was collected by 
passage through a sinter and subjected to rotary 
evaporation. Residual EMS was removed with a water/ether 
separation system where the peptide separated into the 
water phase and the EMS into the ether phase. The water 
phase was washed a further two times with ether and the 
final water phase freeze dried.
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2,9.2 Analysis of the Peptide
2.9.2.1 High performance liquid chromatography (HPLC)
HPLC was performed on a Milton Roy LDC system equiped with 
two constaMetric III metering pumps, a spectroMonitor III 
variable wavelength detector, a solvent mixer unit, a 
Rheodyne injection valve and a plotter all controlled by 
an LDC Chromatography Control Module. A reverse phase 
Hypersil WP-300 butyl 1 0 column (250 mm x 5 mm id) was 
used with a guard column of the same material (50 mm x 5 
mm id). The solvent system consisted of water and 
acetonitrile (both containing 0.1% (v/v) TFA) with a
gradient from 5% (v/v) to 60% (v/v) acetonitrile at a rate 
of 2% change per minute. A flow rate of 1 ml per minute 
was used.
2.9.2.2 Amino acid analysis
Amino acid analysis was performed on a Hilger Analytical 
Chromaspek II. Peaks observed on the HPLC trace were 
collected and dried under vacuum in acid washed glass 
tubes. The samples were resuspended in 6N HC1 ("Aristar") 
and sealed under vacuum. Hydrolysis was carried out at 
105°C for 24 hours. The samples were dried down under 
vacuum and then resuspended in 25 mM HC1 prior to loading 
into the analyser.
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2.10 Raising Antisera to the Synthetic Peptide
2.10.1 Immunisation
Californian white rabbits were used for all immunisations. 
The peptide, dissolved in phosphate buffered saline (PBS), 
was emulsified in Freunds complete adjuvant for initial 
immunisations and Freunds incomplete adjuvant for 
subsequent boosts. Immunisations were performed intra­
muscularly in two sites with lOOyW g peptide per rabbit. 
Boosts were made at two week intervals. Serum samples 
were taken seven days after each boost. Anti serum 109 was 
collected by total bleed after two boosts.
2.10.2 Assaying the Antisera
Blood samples were allowed to clot at 37°c for 60 minutes 
and transferred to 4°C overnight. Samples were then 
centrifuged at 3000 rpm for 15 minutes in an MSE bench 
centrifuge. The supernatant was removed and stored
at -40°C. Antisera were assayed for positive responses to 
the peptide using a dot immunobinding assay (Hawkes e t . 
a l ., 1982) . Aliquots (1 ^  1) were spotted onto
nitrocellulose filters and allowed to dry. The filters 
were transferred to 4°C for 10 minutes to stabilise the 
binding and washed in PBS for 5 minutes. The filters were 
blocked with a solution (1 ml per filter) of 1% (w/v)
casein in PBS (blocking buffer) for 30 minutes at 20°C 
with constant agitation. Antiserum dilutions were made up 
in blocking buffer containing 5% (v/v) normal goat serum
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(NGS). The primary antibody incubation (1 ml per filter) 
was carried out overnight at 20°C with constant agitation. 
The filters were washed (3 x 10 minutes) with blocking 
solution (2 ml per filter) and incubated for 2 hours at 
20°C with a 1/1000 dilution of goat anti rabbit IgG - 
horse radish peroxidase conjugate (1 ml per filter) with 
constant agitation. The filters were then washed with 
blocking buffer (2 ml per filter) and a final wash of PBS 
(2 ml per filter) prior to development. A solution (1 ml 
per filter) of 50 mM sodium acetate, pH 5.0, containing 
0.05% (w/v) 3-amino-9-ethyl carbazole and 0.03% (v/v)
hydrogen peroxide was added to the filters and incubated 
at 20°C until the colour developed, usually about 15 
minutes.
2.11 Western Blotting
Electrophoresis was performed as described in section
2.7.2. To identify tracks on the nitrocellulose sheet, 
methyl green was added, during electrophoresis, to the gel 
tracks approximately half way through the run and then 
again 10 minutes from the end. After electrophoresis, 
protein was transferred to nitrocellulose paper at 30 
volts for 20 hours at 4°C with 25mM potassium phosphate 
buffer, pH 7.4, containing 10% (v/v) methanol as the
blotting buffer. The nitrocellulose sheet was washed (4 x 
15 minutes) with PBS (100 ml) containing 0.01% (v/v) Tween 
20 for 30 minutes at 20°c. Individual tracks were cut out
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and immunostained essentially as previously described in 
section 2.10.2 except that PBS containing 0.2% (w/v)
casein and 0.05% (v/v) Tween 20 was used as blocking
buffer. Protein standards transferred to the
nitrocellulose sheet were stained with indian ink. The 
track containing the standards was washed (2 x 30 minutes) 
at 20°C with PBS (10 ml) containing 0.1% (v/v) Tween 20.
The filter was then incubated overnight at 20°C with PBS 
(10 ml) containing 0.1% (v/v) Tween 20 and 0.1% (v/v)
indian ink. This solution was poured off and the 
individual protein standards were immediately visible. 
This method has the advantage that no destaining is 
necessary. The filters were washed in distilled water and 
dried.
2.12 Precipitation of the o(Bunqarotoxin Binding 
Component with Antisera and Monoclonal Antibodies
The detergent extract prepared as in section 2.3.3 was
used in immunoprecipitation assays. Aliquots (300 y *  1)
were incubated with 5-10 of antiserum for 2 hours at
20°C. IgG was precipitated by incubation at 4°C overnight
with a goat anti rabbit IgG antiserum (100 y  1 per 5 y  1
of rabbit serum), that was raised in this department.
Samples were centrifuged and the supernatant diluted with
an equal volume of buffer. The diluted samples were then 
125
assayed for ( I) o< bungarotoxin binding activity as 
described in section 2.5.5. Experiments with monoclonal
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antibodies were performed essentially in the same way with 
100 yUl of culture supernatant or 5-10 ywl of concentrated 
supernatant. Normal serum (5 y^l) was added as a carrier 
for precipitation by the anti-Ig antiserum.
1252.13 Assay for the Expression of ( I) oC Bungarotoxin 
Binding Sites in Oocytes
Oocytes were injected with total poly A+ mRNA isolated
from locust ganglia and locust whole heads (50 ng). As a
positive control mRNA from Torpedo (50 ng) was used. The
oocytes were allowed to incubate for 48 hours at 23°C
125prior to assay for specific binding of ( I) 
0( bungarotoxin. Oocytes were resuspended in 50 mM 
potassium phosphate buffer, pH 7.2, containing 1 mM EDTA,
1 mM EGTA, 0.1 mM PMSF and 1% (v/v) triton X-100,
homogenised and mixed for 60 minutes at 4°C. Non­
solubilised material was pelleted by centrifugation in an
MSE microcentaur at high speed for 5 minutes. The
125supernatant was assayed for ( I) c* bungarotoxin
binding activity as described for the detergent extract 
(see section 2.5.5).
2.14 Protein Determinations
Protein was determined using the Lowry assay (1951) with 
the modifications suggested by Markmell et. al . (1978).
Aliquots (200 1) containing 10-100 g protein, were
mixed with 600 yw 1 of a solution containing 2% (w/v) di-
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sodium carbonate, 0.4% (w/v) sodium hydroxide, 0.16% (w/v) 
sodium potassium tartrate, 1% (w/v) SDS and 0.04% (w/v)
copper sulphate and incubated for 15 minutes at 20°C.
Folin and Ciocalteu's phenol reagent was diluted 1:1 and 
60 1 added to the each sample with vigorous mixing. The
samples were incubated at 20°C for 45 minutes and the 
absorbance at 660 nm measured. Bovine serum albumin was 




125 33.1 Comparison of ( I) (XBungarotoxin and ( H)(-)
nicotine Binding to the P2G Fraction
Binding assays were performed as detailed in the methods 
section (section 2.5).
3.1.1 The Effect of Varying the Protein Concentration on
125the Binding of ( I) DC Bungarotoxin
125The binding of ( I) (X- bungarotoxin at a fixed 
concentration of 1 nM was measured over the protein 
concentration range 15-110 g . This binding was found to 
be linear thereby suggesting that the binding is directly 
proportional to protein concentration. A representative 
experiment is shown in figure 13.
3.1.2 The Effect of Varying the Protein Concentration on
3
the Binding of ( H)(-)Nicotine
3
At the fixed concentration of 40 nM ( H ) (-)nicotine
(chosen because this would be a saturating concentration
in the case of rat brain) , the binding was measured over 
the protein concentr'at ion range 15-110 y^g. Again the 
binding was found to be proportional to protein
concentration. A representative experiment is shown in
figure 13. All subsequent binding experiments on the P2G
125 3
fraction with ( I) (X bungarotoxin and ( H ) (-)nicotine
were carried out at a protein concentration of 268 + 48 jj<g
per ml (n = 14).
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1253.1.3 Dependence of Binding of ( I) CX. Bungarotoxin on 
Concentration
125Samples were incubated with ( I) c< bungarotoxin over the 
concentration range 0.1-10 nM. A typical binding profile 
for specific binding is shown in figure 14. Saturation is 
seen to occur over this range and the Scatchard analysis 
(Scatchard, 1949) of these data, shown in figure 15, is 
consistent with a single population of sites. A 
dissociation constant (Kd) of 0.8 nM and a maximum number 
of binding sites (Bmax) of 1.2 pmoles per mg protein were 
calculated. The correlation coefficient was 0.98 for this 
Scatchard plot. Specific binding typically represented 
71% of the total binding at 10 nM.
3
3.1.4 Dependence of Binding of ( H)(-)Nicotine on 
Concentration
3
Samples were incubated with ( H) (-)nicotine over the 
concentration range 10-100 nM. The binding profile for 
specific binding is shown in figure 16. Specific binding 
did not reach saturation even at a concentration of 100 nM 
and higher concentrations of ligand were impractical due 
to the cost. Scatchard analysis of these data again 
revealed a single population of sites (figure 17) although 
this must be interpreted with some caution since 
saturation of sites was not achieved. However, from these 
data a Kd of 130 nM and a Bmax of 4 pmoles per mg protein 
were calculated. The correlation coefficient for the
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Scatchard plot was 0.827. Specific binding represented 
65% of the total binding at 100 nM.
3.1.5 The Effect of Washing the P2G Fraction on the
3
Kinetics of ( H ) (-)nicotine Binding
The P2G fraction was washed with either 50 mM potassium 
phosphate buffer, pH 7.4, or distilled water as described 
in section 2.3.1. Neither treatment was found to have the
3
effect of lowering either the Kd or Bmax for ( H)(-)
nicotine binding. Table 2 shows a comparison of the
kinetic parameters calculated from the Scatchard analysis 
for the unwashed, water washed and buffer washed membrane 
preparations. The water washed P2G fraction was found to 
have very similar values to the unwashed P2G fraction. 
However, the buffer washed P2G fraction had a higher Kd 
and Bmax compared to the unwashed P2G fraction.
3.1.6 Determination of Ki Values for Various Nicotinic
125 3Ligands Inhibiting ( I) oC Bungarotoxin and ( H)(-)
Nicotine Binding
All the inhibition studies were performed on the unwashed 
P2G fraction. Table 3 shows a summary of the calculated 
Ki values for the various ligands studied.
3.1.6.1 Stereospecificity of nicotine inhibition
i n r
(-) and ( + ) nicotine were shown to inhibit ( I)
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3
(Xbungarotoxin and ( H )(-)nicotine over the concentration 
-3 -9range 10 -10 M. The displacement curves for the
125inhibition of ( I) (Xbungarotoxin are shown in figure
18, and the calculated K i ' s for (-)nicotine and
-7 -5(+)nicotine were 5.1 x 10 M and 1.5 x 10 M respectively.
This represents a 29 fold stereospecificity in favour of
the (-) enantiomer.
The displacement curve for the inhibition of ( H)(-) 
nicotine binding is shown in figure 19. The calculated
K i ' s were 7.7 x x 10  ^ M and 4.7 x 10 ^ M for (-) and ( + ) 
nicotine respectively. This represents a stereospecificity 
of 6 fold in favour of the (-) enantiomer.
1253.1.6.2 Inhibition of ( I) (Xbungarotoxin binding by 
other nicotinic ligands
Two novel neurotoxins, MLA and (+)anatoxin-a, were shown
125to be potent inhibitors of ( I ) Ot bungarotoxin. The
inhibition curve for MLA is shown in figure 20 and for
( + )anatoxin-a in figure 21. The calculated Ki was 1.8 x 
—810 M for both compounds. (-)Anatoxin-a had a much lower
125potency for inhibiting ( I) (Xbungarotoxin (figure 21)
with a Ki of 1.0 x 10 ^M. DH^3e was also found to be
particularly potent at the (X bungarotoxin site (figure
—8
22). With a Ki value of 1.3 x 10 M it was the most 
potent inhibitor at this site. The vertebrate ganglionic 
nicotinic agonist DMPP was found to have a Ki of 3.8 x
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“610 M and the inhibition curve is shown in figure 23.
High concentrations of atropine were found to inhibit 
12 5( I) otbungarotoxin (figure 24) and the calculated Ki 
_ 4
was 6.3 x 10 M. TEA was also found to have a slight
-4effect with a Ki of 1.8 x 10 M (figure 25). (XBungarotoxin
was not tested in this study but previous studies in this
-9laboratory determined a Ki of 5.3 x 10 M (e.g. Filbin e t . 
a l ., 1983).
3
3.1.6.3 Inhibition of ( H)(-)nicotine binding by other 
nicotinic ligands
With the exception of nicotine itself, all the nicotinic 
ligands tested were virtually ineffective at inhibiting
3
the binding of ( H ) (-)nicotine to the P2G fraction (Table
3). DH^3E (figure 22), DMPP (figure 23) and MLA (figure
20) had Ki values of 1.8 x 10 ^M, 2.0 x 10 and 2.5 x 
-410 M respectively. The Ki values for ( + ) and (-)
-5 —3anatoxin-a (figure 21 ) were >10 M and >10 M respectively.
Even {Xbungarotoxin was found to be only a weak inhibitor
3 —6of ( H) (-)nicotine binding with a Ki of >10 M (figure
_ o
26). The Ki for TEA was calculated to be >10 M (figure
25) ruling out the possibility that this nicotine site may
just be binding any quaternary ammonium ion. The
classical muscarinic antagonist atropine was found to have
-5a Ki of 8.2 x 10 M (figure 24) and therefore was as 
potent as any of the nicotinic ligands tried. 
Decamethonium, the high affinity ligand used to identify
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the mixed AChR in insects (see Introduction section 
1.11.1), was found to have a Ki of 1.4 x 10 (figure 26) 
in this preparation and therefore ( H ) (-)nicotine is 
obviously not binding to the mixed AChR in these 
experiments.
3
3.2 The Vertebrate Neuronal Nicotinic Radioligand ( H)MCC 
Does Not Bind to the P2G Fraction
Binding assays were performed as detailed in the methods 
section. The membrane protein concentration used in these
3
assays was double that used for the assay of ( H)(-)
12 5nicotine and ( I) ^bungarotoxin binding.
3
3.2.1 Effect of Varying the Concentration of ( H)MCC on 
Binding
Figure 27 shows the effect of increasing the concentration 
of (^H)MCC over the range 5-100 nM. (-)Nicotine (10 ^M) 
was used to determine non-specific binding since ( H)MCC 
binds specifically to the high affinity nicotine site in 
vertebrate brain. It is clear that the total and non­
specific binding were almost exactly the same over this 
range. No specific binding could be calculated from the 
lower half of this concentration range. However, at
concentrations of 75 nM and 100 nM a small specific
binding could be calculated although this binding was very
small when compared to the binding of either ( H)(-)
125nicotine or ( I) Xbungarotoxin. This same result was
obtained in two separate experiments.
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3.2.2 Effect of Various Cholinergic Ligands on the
Binding of (^H)MCC
The effect of some classical nicotinic and muscarinic
3ligands on the binding of ( H)MCC is shown in table 4. 
The inhibition is calculated as a percentage of the 
binding of ( H)MCC in the absence of any ligand. It is 
evident that all of the ligands tested had no significant 
effect on the binding of ( H)MCC. (-)Nicotine, atropine 
and TEA showed the highest inhibition although even this 
was very small. o( Bungarotoxin was also found to have no 
effect on the binding of this radioligand. Therefore it 
appears that ( H)MCC does not bind to either the 
Xbungarotoxin binding site or the high affinity nicotine 
site over the concentration range and under the conditions 
tested.
1253.3 Comparison of ( I) X  Bungarotoxin Binding to the
P2H Fraction from Adult and from the Five Instar Stages
125The binding of ( I) 0( bungarotoxin was found to be
linear over the protein concentration ranges tested in the
P2H fraction from the adult and from the five instar
125stages. Figure 28 shows the linearity of ( I)
Xbungarotoxin binding with protein concentration for the 
adult P2H fraction. Similar graphs were obtained for each 
of the five instar stages (not shown). From these data a 
rough estimate of the amount of binding per head compared 
to the amount of binding per mg of protein could be
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calculated and this is shown in figure 29. As would be 
expected the amount of binding per head was found to 
increase with the stage of development, the highest 
binding per head being found in the adult P2H. However, 
the binding per mg protein was found not to vary 
significantly in the different stages of development. It 
is clear then from these data that the best stage of 
insect development to use for purification of the 
(Xbungarotoxin binding component is the adult stage.
3.4 Detergent Solubilisation and Affinity Purification of
the CX Bungarotoxin Binding Component
1253.4.1 Distribution of ( I ) (X Bungarotoxin Binding 
Activity in the Various Fractions During the 
Solubilisation Procedure
An outline of the solubilisation protocol is detailed in
the methods section 2.3.3. Aliquots of each fraction were
taken during the solubilisation procedure and assayed for 
125
( I) (Xbungarotoxin binding activity. Table 5 shows the 
distribution of binding activity in the different 
fractions during this procedure. After the initial 
centrifugation step, the majority of the binding activity 
is localised to the PI fraction with only a small amount 
of activity left in the SI fraction. This PI pellet was 
solubilised in 5% (w/v) Lubrol PX and after
recentrifugation the majority of the binding activity was 
present in the S2 fraction (the detergent extract).
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3.4.2 Effect of Varying the Detergent Concentration on the
125Solubilisation of ( 1) (X Bungarotoxin Binding Activity
The concentration of the non-ionic detergent Lubrol PX was 
varied over the range 0.1-10% (w/v) (table 6 ). The (*^l) 
0< bungarotoxin binding activity present in the detergent 
extract was found to increase with an increase in 
detergent concentration up to a maximum at 3% (w/v) Lubrol 
PX. This activity was found to be very similar over the 
range 1-5% (w/v) Lubrol PX but started to decrease with
increasing concentrations from 5-10% (w/v) Lubrol PX. A
concentration of 3% (w/v) Lubrol PX was routinely used for 
subsequent purifications of the (Xbungarotoxin binding 
component.
3
3.4.3 The Binding of ( H) (-)Nicotine to the Detergent 
Extract
3The binding of ( H ) (-)nicotine to the detergent extract
was measured at three concentrations (table 7). Very
little binding was detected even at a concentration of 100
nM. This binding is not significant when compared to the 
125
binding of ( I) (X bungarotoxin to the same extract. 
However, the nicotine binding site may be very labile and 
difficult to assay when solubilised from the membrane and 
this may account for so little binding.
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3.4.4 The Purified cX Bungarotox in Binding Component
The (Xbungarotoxin binding component was affinity purified
from the detergent extract as detailed in section 2 .6 .2 .
Figure 30 shows a typical elution profile from the DE52
ion exchange column in a purification experiment using 200
125ganglia as starting material. The majority of the ( I)
(Xbungarotoxin binding activity was always present in one
fraction. Direct elution from the affinity column with d-
_ 3
tubocurarine (10 M) followed by dialysis to remove the
ligand was also tried. However, a greater yield of
purified protein was achieved by the recirculation method
onto a DE52 column. This may be explained by loss of
protein during dialysis. The recirculation method was
used for all subsequent experiments. Purifications were
routinely carried out on either 100 or 200 ganglia.
Attempts were made with various protein assay methods
(Pierce assay (Smith et. a l ., 1985), Lowry assay (Lowry
et. a l ., 1951), modified Lowry assay (Markmell et . a l .,
1978) and Bradford assay (Bradford, 1976)) to attempt to
determine the quantity of protein eluted from the DE52
column. However, no method with the required sensitivity
was found and problems of interfering chemicals in the
preparations made the determination of protein content
impossible. An estimate of the protein content could,
however, be made assuming that each 49,000 dalton
polypeptide (see section 3.4.5) binds one molecule of
125 >(Xbungarotoxin and from the number of pmoles of ( I)
75
(X bungarotoxin binding activity in the sample, it is
possible to estimate the weight of protein present. Table
125
8 shows the number of pmoles of ( I ) bungarotoxin 
binding activity purified from 100 ganglia in 16 different 
purifications along with the protein weight equivalents. 
The highest protein content was 1.6yLvg per 100 ganglia and 
it is therefore not surprising that the protein assays 
tried were not sensitive enough to quantify the protein 
content.
3.4.5 Analysis of the Purified p( Bungarotoxin Binding 
Component by SDS-PAGE
The o( bungarotoxin binding component was prepared for 
SDS-PAGE as described in section 2.7.1. A large
proportion of the detergent and salt present in the sample 
was removed by this procedure. Due to the low quantity 
of (Xbungarotoxin binding component that could be purified 
(see section 3.4.4), the normal coomassie blue staining 
procedure was not sensitive enough and a silver staining 
method was used (section 2.7.3.1). A typical gel pattern 
is shown in figure 31. The predominant band present has a 
Mr of 49,000. Occasionally other minor bands were 
observed, but were so faint as to be virtually impossible 
to record on film. However, figure 31 shows one such gel 
where there are faint bands with calculated Mr's of
58,000, 61,000 and 66,000. Pur ifications where there were 
other bands present as well as the main band at Mr 49,000,
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are shown in figure 32 (lanes 2, 3 and 4). It is not
clear whether these bands represent true polypeptides of 
the (Xbungarotoxin binding component or whether they are 
just minor contaminents. The only consistent band in all 
the purifications made, was at Mr 49,000. Figure 32 shows 
the consistency of the predominant 49,000 band in seven 
separate purifications. However, in two of these
preparations an additional strong band (possibly a 
doublet) is seen at Mr 66,000 (lanes 3 and 4). This band
at Mr 66,000 was observed a third time as shown in figure
33, lane 1. In this preparation bands were also present 
at 49,000, 46,000 and 44,000. An (Xbungarotoxin binding 
protein has been purified from another locust, Locusta 
migratoria, by Breer (1984). This protein is thought to 
be composed of four or five identical subunits of Mr
65,000. Therefore, the (Xbungarotoxin binding component 
was purified from Locusta migratoria ganglia, using the 
same procedure as for Schistocerca gregaria in this study. 
The subunit pattern comparison on SDS gels is shown in 
figure 33. The calculated Mr for the Locusta migratoria 
(Xbungarotoxin binding component was 51,000 compared to 
the usual 49,000 band seen for Schistocerca gregaria.
The effect of temperature, pH and the presence of protease 
inhibitors on the subunit pattern of the Schistocerca 
gregaria (Xbungarotoxin binding component on denaturing 
gels was investigated. By keeping the whole procedure for
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purification at 4°C there was no difference in the subunit 
composition of the purified protein. Similarly there was 
no difference whether the protein was purified at pH 6.5,
7.4 or 8.0. The protease inhibitors pepstatin A, 
bestatin, leupeptin, lima bean tryspin inhibitor, soya 
bean tryspin inhibitor (all at a final concentration of 10 
yug per ml) and PMSF (0.5 mM) were added to the buffers 
used in the purification procedure. Again no effect on 
the subunit pattern was seen by the inclusion of these 
inhibitors. Proteolysis certainly presents a problem in 
the purification of this protein as demonstrated in figure 
34. This shows the denaturing gel of a sample of the 
purified cX bungarotoxin binding protein which had been 
stored at 4°C for seven days compared with a freshly 
prepared sample. It is clear that the major band present 
has moved to a Mr of 43,000. The presence of proteolytic 
activity was also detected when the eluted fraction from 
the DE52 column was dialysed prior to precipitation. 
Figure 35 shows an example of this where most of the 
protein is found at the dye front indicating that the 
protein present has been severely proteolysed. No way was 
found of overcoming this proteolytic problem.
3.4.6 Attempts to Sequence the 49,000 Dalton Band 
Attempts to obtain protein sequence were performed by the 
AFRC unit at Babraham. For the initial attempt at 
sequencing, the (Xbungarotoxin binding component in the
78
fraction containing highest binding activity was 
chloroform/methanol precipitated and resuspended in 0 ,1% 
(w/v) SDS. However, the sequencing results indicated that 
there was not enough protein present in the sample and 
that there was possibly more than one N-terminal present. 
In the second attempt, the CL bungarotoxin binding 
component was purified from one thousand ganglia and sent
to the AFRC unit. The result of this attempt was that the
protein had a blocked N-terminal. No further attempts 
were made to sequence the protein.
3.5 (^H)MBTA Labelling of the P2G Fraction
Figure 36 shows the gel slice profiles for total, non­
specific and specific labelling of a denaturing gel of the 
P2G fraction labelled with the nicotinic affinity ligand 
( H)MBTA as detailed in the methods section. There was 
labelling all the way along the gel and this can be 
attributed to a greater amount of protein being loaded 
onto the gel corresponding to the total labelling sample. 
Using (-)nicotine to determine non-specific labelling, a 
predominant band was specifically labelled with a Mr of
49,000. Two other major specific peaks were observed 
corresponding to Mr of 205,000 and 30,000. The 205,000 
band may represent the intact protomer of the receptor and
the band at 30,000 may correspond to a possible
proteolysis band sometimes observed on silver stained 
denaturing gels of the purified bungarotoxin binding 
component. A similar result was obtained in two 
experiments.
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3.6 Synthesis of a Synthetic Peptide Corresponding to the 
Dicysteine Loop Region
The protein sequence of the peptide to be synthesised was 
taken from the locust non-alpha clone isolated from a 
genomic library of Schistocerca gregaria (Marshall e t . 
a l ., 1988). This region of the polypeptide chain is very
highly conserved (see Introduction and figure 8 ). The 
peptide was synthesised, as detailed in section 2.9, with 
cysteine residues containing an acetamidomethyl group to 
protect the side chain. Use of this residue has the 
advantage that it is difficult to remove and is therefore 
not removed when the peptide is cleaved from the resin. 
The resulting peptide is therefore linear rather than 
cyclised. This linear form of the peptide was synthesised 
since problems in achieving correct cyclisation were 
envisaged. An initial trial cleavage was performed (as 
detailed in section 2.9.1.4) on a small sample of the 
resin prior to treatment of the bulk.
3.6.1 HPLC analysis of the trial cleavage
The peptide was cleaved from the resin with 5% (v/v) EMS 
in TFA. The trial cleavage was carried out on 50 mg of 
resin. The peptide obtained was analysed by HPLC and the 
trace obtained is shown in figure 37. Two major peaks 
were identified at retention times of 8.06 (peak 1 ) and 
20.87 (peak 2) minutes. A smaller third peak at 22.96 
minutes (peak 3) was also detected. Samples of each of
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these peaks were taken and analysed for amino acid 
composition.
3.6.2 Amino acid analysis of peaks 1, 2 and 3
Table 9 shows the amino acid analysis of peak 2. Peaks 1 
and 3 were found not to be peptidic whereas peak 2 gave 
the correct amino acid composition for a peptide of the 
required sequence. In the amino acid analysis, the 
cysteine content was found to have a low value. This was 
expected since the cysteine residues were modified with 
the acetimidomethyl group. Therefore, the position of the 
modified cysteine in the amino acid analysis trace could 
be different from the unmodified cysteine position. The 
presence of carboxymethyl cysteine was detected and 
therefore could have been due to the modified cysteine 
residues.
3.6.3 Second cleavage
A second cleavage was performed on 200 mg of resin. The 
HPLC trace of a sample of this cleavage is shown in figure 
38. The products of this cleavage experiment were found 
to be different from the initial cleavage. There was a 
peak at retention time 7.94 minutes and this was assumed 
to be the same as peak 1 from the previous trial cleavage. 
Two other peaks were evident at retention times 18.99 and 
19.95 minutes (called peaks 4 and 5 respectively). The 
presence of peaks 2 and 3 was not detected in this
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cleavage. Samples of peaks 4 and 5 were collected and 
analysed for amino acid content.
3.6.4 Amino acid analysis of peaks 4 and 5
The amino acid analysis of peaks 4 and 5 is shown in table
9. Both samples were found to be correct for a peptide
with the required sequence with the exception that the
value for tyrosine was very low in each sample.
Therefore, both of these peptides may have been partially 
deprotected species of the peptide and it seems likely 
that it was the tyrosine residue that still contained a
protecting group resulting in the low appearance of this 
residue in the amino acid analysis. The values for
cysteine were again low again consistent with the
modification by acetimidomethyl groups.
3.6.5 Further treatment of the products of cleavage 2 
The peptide was retreated by repeating the cleavage
process on the freeze dried sample from cleavage 2. HPLC 
analysis of the retreated sample is shown in figure 39.
It is clear that both peaks 4 and 5 disappeared and a new
peak appeared at retention time 20.76 minutes (peak 6 ). 
This HPLC trace is similar to that from the initial 
cleavage (figure 37). Amino acid analysis of peak 6 was 
correct for the required peptide (table 9) and essentially 
the same as for peak 2. Approximately 20 mg of peptide
was recovered from the 200 mg of resin.
82
3.7 Antisera to the Synthetic Peptide
Four rabbits were immunised as described in section
2.10.1. All four antisera were found to be positive for 
reaction with the peptide and peptide conjugated to either 
BSA or hemoglobin, using the dot blot immunobinding 
assay. Figure 40 shows the assay for the antisera 109 and
110. Antisera 111 and 112 had equally strong responses.
3.8 Antibody Studies on the Bungarotoxin Binding Protein
3.8.1 An Antiserum to the 0( Bungarotoxin Binding Protein 
Cross Reacts With the Synthetic Peptide
An antiserum (Anti-L) which was raised against the locust 
0( bungarotoxin binding component by Colette O'Sullivan in 
this laboratory by repeated immunisation with small
quantities of the purified protein was shown to cross 
react with the synthetic peptide. A typical dot blot 
immunobinding assay result of this is shown in figure 41 
along with that for antiserum 109. Anti-L was found to be 
much weaker with the response being diluted out at a 
dilution of 1/500.
3.8.2 Do Antibodies Recognise the Bungarotoxin Binding 
Component?
Various antibodies were tested for their ability to 
precipitate the o(bungarotoxin binding component from the 
detergent extract. The results are shown in table 10. 
Anti-L was found to have a moderately high titre at around
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21 nM. This means that 5 1 of the serum would
125precipitate 0.1 pmoles of ( I) oC bungarotoxin binding
activity. An antiserum raised against purified Torpedo
nAChR (Anti-T), raised by Colette O ’Sullivan in this
laboratory, had a titre of 8 nM (5 yu 1 precipitated 0.04 
125pmoles of ( I) (X bungarotoxin binding activity) and
therefore shows a small amount of crossreactivity of the
locust 0(bungarotoxin binding protein with the Torpedo
nAChR. Four monoclonal antibodies raised against the
purified Torpedo nAChR in this laboratory by Susan Walsh
(Mab Bll, Mab C07, Mab Cll and Mab E08) were found not to 
125precipitate ( I) o( bungarotoxin binding activity from
the detergent extract. Additionally, Mab 270 raised
against the chick brain nAChR (Lindstrom et. al. 1987a)
and M a b ’s 290 and 299 raised against the rat brain nAChR
(Whiting and Lindstrom, 1988) were unable to precipitate 
125( I) (X bungarotoxin binding activity from the detergent
extract. Antiserum 109, (As 109, raised against the
synthetic peptide) was also found not to be able to
125
precipitate the ( I) (X bungarotoxin binding component in 
this assay. In these precipitation experiments, the 
negative controls consisted of normal rabbit serum for the 
antisera and normal culture medium and an anti­
neurofilament monoclonal antibody for the monoclonal
antibodies. As 109 was also tested for its ability to
125inhibit ( I) oC bungarotoxin binding to the detergent 
extract (table 11) and the P2G fraction (table 12).
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However, no significant inhibition of binding was observed 
in either case.
3.8.3 Western Blots
The four anti peptide antisera (109, 110, 111 and 112) 
were tested for activity in Western blots. The preimmune 
serum for each antiserum was used as the control 
experiment. Each antiserum interacted with several bands 
which were determined non-specific due to their presence 
in the preimmune serum stained blots. Only one of the 
antisera, As 109, was found to detect two specific bands 
compared to the preimmune serum (figure 42). These 
specific bands had Mr's of 49,000 and 60,000. A non­
specific band was also present which had a Mr of 58,000. 
This result was obtained in two separate experiments. As 
a control, As 109 was tested in a Western blot using a 
locust flight muscle membrane fraction as antigen. No 
specific bands were detected in this experiment.
The purified <Xbungarotoxin binding component from 400 
locust ganglia was combined and split between two lanes of 
a denaturing gel which was subsequently blotted onto 
nitrocellulose as detailed in the methods section and 
immunostained with As 109. The only detectable band was 
found with a Mr of 58,000 (figure 43). In a parallel 
experiment a silver-stained gel of the combined purified 
protein showed the major band at a Mr of 49,000.
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Therefore the difference in Mr may be explained by high 
concentrations of either salt or detergent in the protein 
sample prepared for Western blotting interfering with the 
mobility of the protein during electrophoresis. In fact 
during the running of the gel diffusion of the dye front 
was observed. For a silver stained gel purified material 
from only 25 ganglia is required and therefore the 
concentration of salt and detergent was 8 times as high in 
the sample for the Western blot. Therefore, it is 
reasonable to assume that the As 109 does in fact 
recognise the Mr 49,000 band characteristic of the 
(X bungarotoxin binding component.
3.9 Expression of Locust Ganglia o(. Bungarotoxin Binding 
Sites in Oocytes
Oocytes were injected with total polyA+ mRNA as detailed
in the methods section. Table 13 shows the results of 
125
( I) 0C bungarotoxin binding experiments where oocytes 
were injected with mRNA extracted from locust heads and 
locust ganglia, and a positive control experiment where 
oocytes were injected with mRNA from Torpedo. Control 
oocytes, which were not injected, were also included. For 
the oocytes injected with locust ganglia mRNA, the binding 
was variable with the highest binding observed at 0.243 
pmoles per oocyte. This was very similar to the value 
obtained for the oocytes injected with Torpedo mRNA. No 
binding to uninjected oocytes was observed in any
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experiment. Therefore, it is clear that CX bungarotoxin 
binding sites have been expressed in these oocytes 
directed by mRNA extracted from locust ganglia, although 
the levels expressed were quite low and this may be due to 
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Figure 6 : A model of the three-dimentional shape of the
nAChR from Torpedo californica. The positions of 
the subunits around the central well are tentative 
assignments.
(Y\cCcxr-tUj ek oX f
Figure 7 : Three models of the arrangement of secondary 
structure of the Torpedo o(subunit in the 
membrane. Model 1 is from Noda e£. a l . , 1982, 
Devillers-Thiery e_t. a l ., 1983 and Claudio e t . 
a l . , 1983. Model 2 is from Guy, 1984 and Finer-Moore 
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Figure 8 : Alignment of the cysteine loop amino acid sequence 
of the subunits of Torpedo, vertebrate brain and insect brain.
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Figure 10 : Outline of the procedure for the preparation of the 
detergent extract.
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Figure 13 : Effect of varying the protein concentration
12 5on the binding of ( I) oCbungarotoxin (•-• 
( H )(-)nicotine (o-o) to the P2G fraction. 
(Results are typical of three experiments 
carried out in triplicate). At each protein 
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I ] (XBungaro tox in  concen t ra t ion  (nM)
12 5Figure 14 : The dependence of binding of ( I )o( bungarotoxin 
to the P2G fraction on concentration (0.1 - 
10 nM)
(This result is from one experiment carried 
out in triplicate, typical of two). At each 
concentration, SD < 6%.
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Figure 15 : Scatchard analysis of the binding data 
in figure 14. From the data a Kd of 0 
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3
Figure 16 : The dependence of binding of ( H )(-)nicotine
to the P2G fraction on concentration (0-100 nM) 
(This result is from one experiment carried out 
in triplicate, typical of three). At each 
concentration, SD <  8%.
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Figure 17 : Scatchard analysis of the binding data shown 
in figure 16. From this data a Kd of 130 nM 















Log concentration displacing ligand
125Figure 18 : Inhibition of ( I) (X bungarotoxin binding to 
the P2G fraction by (-) (•-•) and (+) (o-o)
nicotine. (Results are typical of two experiments 
carried out in triplicate). Ki values shown in 













Log concentration displacing ligand
Figure 19 : Inhibition of ( ) ( - ) nicotine binding to the 
P2G fraction by (-) (•-•) and ( + ) (o-o)
nicotine. (Results are typical of three 
experiments carried out in triplicate). Ki 
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Log concentration displacing ligand
125: Inhibition of ( I) (X bungarotoxin (•-•) 
and ( ) ( - ) nicotine (o-o ) binding to the P2G 
fraction by MLA. (Results are typical of 
three experiments carried out in triplicate). 
















Log concentration displacing ligand
12 5Figure 21 : Inhibition of ( I) o( bungarotoxin (•-•;o-o) 
and (3H ) (-)nicotine (■-■;□— □) binding to the 
P2G fraction by ( + ) anatoxin-a (•-•;»-■) and 
(-) anatoxin-a (o-o;o-o). (Results are 
typical of three experiments carried out in 
triplicate). Ki values shown in table 3,
SD <  8%.
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Log concentration displacing ligand
Figure 22 : Inhibition of ( I) (Xbungarotoxin (•“• ) and
3 '
( H )(-)nicotine (o-o ) binding to the P2G fraction
by DH/3E. (Results are typical of three 
experiments carried out in triplicate). Ki values 
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Log concen t ra t ion  d isp lac ing l igand
12 5Figure 23 : Inhibition of ( I) (X bungarotoxin (•-•) and
3
( H )(-)nicotine (o-o) binding to the P2G 
fraction by DMPP. (Results are typical of 
three experiments carried out in triplicate).
















Log concen tra t ion  d isp lacing l igand
12 SFigure 24 : Inhibition of ( I) (X bungarotoxin (•-•) and
( ) ( - ) nicotine (o-o) binding to the P2G 
fraction by atropine. (Results are typical of 
two experiments carried out in triplicate).
















Log concen tra t ion  displacing ligand
12 5Figure 25 : Inhibition of ( I) oC. bungarotoxin ( •-•) and 
( ) ( - ) nicotine ( o-o) binding to the P2G 
fraction by TEA. (Results are typical of two 
experiments carried out in triplicate). Ki 
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Figure 26 : Inhibition of ( ) ( - ) nicotine binding to the 
P2G fraction by oCbungarotoxin (•-•) and 
decamethonium (o-o ). (Results are typical of 
two experiments carried out in triplicate).











[ 3 h ]  MCC concen t ra t ion  (nM)
Figure 27 : The effect of increasing the concentration of 
(3H )MCC on binding to the P2G fraction 
(5-100 nM). (This result is typical of two 
experiments carried out in triplicate). SD < 9%. 















Protein concen t ra t ion  (mg)
Figure 28 : Effect of varying the protein concentration
12 5on the binding of ( I) oCbungarotoxin to the 
P2H fraction prepared from adult heads. Using 
the same protein concentration ranges, similar 
graphs were obtained for the P2H fraction 
prepared from the heads of lst-5th instars.
(This result is from one experiment carried 
out in triplicate, typical of three). SD <  10%.
125Figure 29 : A comparison of ( I) (Xbungarotoxin binding to the 
P2H fractions from adult (A) and lst-5th instars 
(1-5) calculated from linearity of binding versus 
protein concentration experiments (e.g. see figure 
28). (Results are the means of three experiments and 
the error bars represent the ranges).
(a) Binding expressed as pmol/head
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Figure 30 : Elution of the bungarotoxin binding protein 
from the DE52 cation exchange column with 
buffer containing 1M NaCl. (This result is 
from one experiment carried out in triplicate 
typical of 16, see table 8). For this 
experiment SD <  5%.
Figure 31 : A typical silver stained denaturing gel of the 
0( bungarotoxin binding protein purified from 
Schistocerca gregaria.
Lane 1 : The purified cXbungarotoxin binding protein 
Lane 2 : Molecular weight standards
118
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Figure 32 : A silver stained denaturing gel of seven different preparations 
of the CXbungarotoxin binding protein from Schistocerca 
gregaria showing the consistency of the 49,000 dalton band.
Lanes 2 - 8  : The purified o( bungarotoxin binding protein







Figure 33 : A comparison of the CXbungarotoxin binding protein 
purified from Locusta migratoria and Schistocerca 
gregaria, analysed on a silver stained denaturing gel
Lanes 1, 3 : Schistocerca gregaria 
Lane 4 : Locusta migratoria
Lanes 2, 5 : Molecular weight standards
— t 2 3 .5K
Figure 34 : A silver stained denaturing gel of the purified OCbungarotoxin 
binding protein from Schistocerca gregaria showing the effect 




: The purified OCbungarotoxin binding protein which 
had been stored at 4°C for seven days 
: A freshly prepared sample of the oCbungarotoxin 
binding protein 








Figure 35 : A silver stained denaturing gel of the purified
OCbungarotoxin binding protein from Schistocerca 
gregaria showing the effects of dialysis prior to 
electrophoresi s .
Lanes 3, 4 : Samples of purified
(X bungarotoxin binding protein 
that had been dialysed 
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Figure 36 : Gel slice profile for the specific labelling 
of the P2G fraction with (3H)MBTA. (This 
result is from one experiment typical of two).
Opposite page: Gel slice profile for the total and non-specific labelling of the P2G
fraction with [3 H]MBTA. Non-specific labelling was determined in the presence of
(-)nicotine (10"3 M).
•  : Total binding. 0-0 : Non-specific binding.
Figure 37 : HPLC analysis of the products from the initial 
trial cleavage of the peptide from the resin. 
Conditions of analysis were as described in 
section 2 . 9 . 2.1.
Figure 38 : HPLC analysis of the products from the second 
cleavage of the peptide from the resin. 
Conditions of analysis are described in section 
2.9 .2.1 .
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Figure 39 : HPLC analysis of the retreated peptide
material from cleavage 2. Conditions of 
analysis are described in section 2.9.2.1.
Figure 40 : Dot blot immunobinding assay for antisera 109 and
110, raised against the synthetic peptide
Blot 1 • Preimmune serum 109
Blot 2 • Antiserum 109
Blot 3 : Preimmune serum 110
Blot 4 : Antiserum 110
Spots A • BSA (1 y^g/spot)
Spots B : BSA-peptide conjugate (1 y^g/spot)
Spots C • Haemoglobin-peptide conjugate (ly^  
g/spot)
Spots D, E : Peptide alone (100 ^g/spot)
All serum dilutions were at a dilution of 1/50

Figure 41 : A dot blot immunobinding assay showing the crossreactivity of
antiserum Anti-L with the synthetic peptide.
Column A : Antiserum 109
Column B : Anti-L
Column C : Preimmune serum 109
Row 1 : 1/20 dilution of serums
Row 2 : 1/100 dilution of serums
Row 3 : 1/500 dilution of serums
100 ng of peptide was spotted onto each filter.
128
CO to ^




Figure 42 : Western blot of the P2G fraction analysed with AS 109
Lane 1 : AS109 1/100 dilution






Figure 43 : Western blot of the purified cXbungarotoxin binding 
component analysed with AS 109.
Lane 1 : AS109 1/50 dilution
Lane 2 : Preimmune serum 109 1/50 dilution
130
116K\_










Fruitfly Whole head - - 900 Dudai, 1977
Fruitfly Whole head 1.1 - 887 Schmidt-Nielsen et. al., 1977
Fruitfly Whole head 1.9 0.6 800 Dudai, 1978
Fruitfly Whole head 1.8 - 190 Rudloff, 1978
Fruitfly Whole head 0.16 0.14 - Jiminez and Rudloff, 1980
Housefly Whole head - 0.68 - Harris e£. al_., 1979
Housefly Whole head 3.1 - 204 Cattell et. al., 1980
Housefly Whole head 3.0 - 2000 Eldefrawi and Eldefrawi, 1980
Housefly Whole head 5.6 - 23* Jones et. al., 1981
Locust Cerebral ganglion 1.1 0.8 1775 Breer, 1981a
Locust Cerebral ganglion 1.38 - 1180 Filbin et. al., 1983
Cockroach Nerve cord 4.8 0.6 910 Lummis and Sattelle, 1985
Honeybee Whole head 3.0 - 1000 Sherby et. al., 1986
125Table 1 : A comparison of the published binding parameters for [ l]o(bungarotoxin binding to 
membrane fractions prepared from the CNS of various insects.
* Units for this value are pmol/g of heads.
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Treatment Kd (nM) Bmax (pmol/mg)
Unwashed + 130 ± 9 4.102 ± 0.484
Buffer washed * 170 5.600
Water washed * 128 3.997
* single experiment carried out in triplicate
+ results are the average of three experiments carried out 
in triplicate ± S.D.
Table 2 : Comparison of the effect of washing the P2G
3
fraction on the binding of ( H ) (-)nicotine. 
Binding was measured as described in the 
methods section over the concentration range 
for (^H)(-)nicotine of 0 - 100 nM.
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Ki's (M)
3 125Ligand ( H) (-) nicotine ( I) (Xbungarotoxin
(+)Anatoxin-a -5> 1 0 1.8 X
001or—1
(-)Anatoxin-a >  10"3 1.0 X 10”4
(-)Nicotine 7.7 x IQ'7 5.1 X 10-7
(+)Nicotine 4.7 x 10“6 1.5 X 10"5
MLA 2.5 x 10“4 1.8 X h-> o
1 00
DHjS>E 1.8 x 10"4 1.3 X 10-8
DMPP 2.0 X o
1
3.8 X 10-6
Atropine 8.2 x 10"5 6.3 X io”4
TEA >  10"3 1.8 X 10-4
c< Bungarotox i n >  10"6 -
Decamethonium 1.4 x 10"4 -
Table 3 : Inhibition of (3H ) (-) nicotine and (^^1)
oCbungarotoxin binding to the P2G fraction by 
various cholinergic ligands. Results are the 
average of either 2 or 3 experiments carried 
out in triplicate S.D. <^8%. Binding assays 
were performed as described in the methods
3
section with ( H ) (-)nicotine at a
125concentration of 50 nM and ( I)
(Xbungarotoxin at a concentration of 1 nM. Ki
values were derived from IC__ values by the
5 0
method of Cheng and Prusoff, 1973 assuming Kd 
values of 130 nM for (3H )(-)nicotine and 1 nM 
for ( l^l) CXbungarotoxin.
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Ligand Cone11 %Total Binding
(-)Nicotine i o " 3m 87.5
MLA i o "3m
-3
94.9











TEA 10 M 91.7
oC Bungarotoxin i o ~6m 98.5
Table 4 : Inhibition of (3H)MCC binding to the P2G
fraction by cholinergic ligands. Binding
assays were performed as described in the
3
methods section. ( H)MCC was at a
concentration of 50 nM. Results are the means
of three experiments carried out in triplicate 











55.35 100.0 40.81 1.356
S1 0.85 1.5 9.49 0.089
P1 60.93 110.0 23.94 2.545
S2 (detergent 
extract)
45.28 81.8 19.52 2.320
P2 0.34 0.6 0.94 0.362
125Table 5 : Distribution of ( I) (Xbungarotoxin binding
activity in the solubilisation procedure.
Binding assays were performed as detailed in
125
the methods section with ( I)
(Xbungarotoxin at a concentration of 10 nM. 
Results are the means of three experiments 









P1 membranes 65.61 100.0 25.32 2.591
0.1% Lubrol PX 29.88 45.5 17.67 1.691
1% Lubrol PX 50.52 77.0 20.01 2.525
3% Lubrol PX 51.96 79.2 20.26 2.565
5% Lubrol PX 50.40 76.8 20.74 2.430
10% Lubrol PX 41.16 62.7 21.24 1.938
125Table 6 : Effect on the solubilisation of the ( I)
OC bungarotoxin binding component by varying
125the detergent concentration. ( I)
(X bungarotoxin was at a concentration of 10 
nM. Binding assays were performed as
described in the methods section. Results are 




( H ) (-)Nicotine concentration 
(nM)




Table 7 : ( ) ( - ) Nicotine binding to the detergent
extract. Binding assays were performed as 
detailed in the methods section. Results are 
the mean of two independent experiments 
carried out in triplicate S.D. <  6%.
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125Table 8 : A comparison of the quantity of ( I)
o( bungarotoxin binding activity purified from
different preparations. Protein weight
equivalents were calculated assuming a 1:1 
125binding of ( I) o<bungarotoxin to the 49,000
Mr polypeptide. Binding assays were performed
125as detailed in the methods section with ( I) 
o{ bungarotoxin at a concentration of 10 nM. 





%Area / %Area 
Peak 4
for Lysine 
Peak 5 Peak 6 Expected
Asp 2.157 2.070 2.124 2.089 2
Thr 3.222 2.687 2.873 2.971 3
Ser 2.134 1.684 1.890 2.013 2
Gin 3.503 3.190 3.241 3.382 3
Cys 0.501 0.703 0.818 0.928 2
Val 0.972 0.926 1.205 0.963 1
Met 0.842 0.946 0.944 0.958 1
H e 1.818 1.936 1.913 1.949 2
Tyr 0.811 0.203 0.344 0.785 1
Phe 2.295 2.419 2.318 2.352 2
Lys 1.000 1.000 1.000 1.000 1
Table 9 : Amino acid analysis of peptides identified by
HPLC. The peak area for each amino acid was 
determined from the analysis trace and the 
percentage area was related to that for 
lysine, since lysine was the first amino acid 
in the sequence. Proline was also present in 
all the peptide fractions analysed, detected 
at 440 nM instead of 570 nM. The values for 
cysteine are lower than expected, possibly due 
to the fact that the protecting group was not 
removed by the cleavage process.
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Table 10 : Immunodepletion studies. These binding
experiments were performed as detailed in the 
methods section. Results are the average of 
three experiments carried out in triplicate 






125( I) oC bungarotoxin 
bound (CPM)
% Inhibition
Buffer 10 574226 -
o(Bungarotoxin 10(10 5M) 76676 86.6
Preimmune 10 467152 -
A.s 109 10 461337 1.2
Preimmune 5 498864 -
As 109 5 488327 2.1
Preimmune 2 497291 -
As 109 2 489706 1.5
Table 11 : Lack of 125inhibition of ( I ) <X bungarotoxin
binding to the detergent extract by As 109. 
125The assay of ( I) c< bungarotoxin binding to 
the detergent extract was performed as 
detailed in the methods section. Sample
additions were incubated for 60 minutes at
o 12520 C prior to addition of ( I )o(bungarotoxin
(final concentration of 10 nM) . Preimmune
serum was used as the control binding from
which the inhibition by As 109 could be
calculated. Results are from a single




125Volume ( I) bungarotoxin 
(ywl) bound (CPM)
% Inhibition
Buffer 10 51069 -
o( Bungarotoxin 10(10“ 5M) 6973 86.4
Preimmune 10 48216 -
As 109 10 47829 0.8
Preimmune 5 49351 -
As 109 5 49184' 0.3
125Table 12 : Lack of inhibition of ( I) ct bungarotoxin
binding to the P2G fraction by As 109. The 
125assay of ( I) Ot bungarotoxin binding to
the P2G fraction was performed as detailed in
the methods section. Sample additions were
incubated for 60 minutes at 20°C prior to
125addition of ( I) bungarotoxin (final 
concentration of 10 nM). Preimmune serum was 
used to determine control binding from which 
the inhibition by As 109 could be calculated. 




12 5( I) OCbungarotoxin bound 
(pmol / oocyte)






2 locust ganglia 
mRNA
0.020






Table 13 : Assay of specific binding to detergent
extract of oocytes injected with mRNA.
Control uninjected oocytes were assayed
alongside in each experiment and no binding
was detected. Binding was assayed as
detailed in the methods section with 
125
( I ) oC. bungarotoxin at a concentration of 
10 nM.
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Kd (nM) 130 9 0.8 1.5
Bmax (pmoles/ 4 0.1 1.2 0.06
mg protein)
Table 14 : Comparison of the binding characteristics of
3 125( H ) (-)nicotine and ( I) oc Bungarotoxin
binding to the locust P2G fraction and a rat
brain P2 membrane fraction. (Reproduced from
MacAllan et . a l ., 1988).
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RANK ORDER OF POTENCY OF LIGANDS
( ) ( - )Nicotine 125( I) OC Bungarotoxin
Rat Locust Rat Locust




(-)NIC (+)NIC (+)ANA MLA it
(-)ANA (+)ANA * (-)NIC (+)ANA
DHySE DH^E (-)ANA (-)NIC
MLA MLA DH0E (+)NIC
(+ )NIC (- )ANA LOWE:st (+ )NIC (-)ANA
TABLE 15 : A comparison of the rank order of potency of
3
several cholinergic ligands inhibiting ( H)
125(-)Nicotine and ( I) (X. bungarotoxin binding 
to the locust P2G fraction and rat brain P2 
membranes. (Rat brain data taken from
MacAllan et. al., 1988).






The work reported here has focussed on attempts to further
characterise the putative nAChR of insect ganglia.
Previously published work on this receptor has relied
almost entirely on the use of c*C bungarotoxin, therefore a
125comparison was made of the binding of ( I)
3 3<X bungarotoxin, ( H) (-) nicotine and ( H)MCC to a locust
P2G membrane fraction. These results will be compared to
a parallel study carried out on rat brain P2 membranes by
Dr Sue Wonnacott (MacAllan e t . a l ., 1988) and the
significance of the insect binding sites will be
discussed. Attempts at improved purification and
characterisation of the bungarotoxin binding protein have
also been made in this study and these results are
compared with those from other insects. Finally, this
discussion will describe early results in the application
of molecular biology to the identification of the insect
nAChR and the future direction in this field.
4.1 Criteria for the Identification of Neurotransmitter 
Receptors
Characterisation of neurotransmitter receptor proteins 
usually starts with the identification of specific binding 
sites for a radiolabelled ligand. However, this alone is 
not sufficient to classify the binding site as a 
physiological receptor and further characterisation must 
be made. The criteria for the identification of a 
physiological neurotransmitter receptor are as follows
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1) Identification of a specific binding component 
for the transmitter or a well characterised 
agonist or antagonist which saturates with 
increasing concentrations;
2) Specific binding should increase linearly with 
protein concentration;
3) Specific binding should be displaced by 
pharmacologically related ligands at
physiological concentrations but not by ligands 
of different pharmacological specificity.
4) Specific binding sites must be localised to areas 
known to show physiological responses to the 
ligand.
5) Specific binding sites should be isolated, 
purified and characterised biochemically.
6) The isolated specific binding protein should be 
reconstituted into an artificial lipid bilayer 
and be shown to have the functional properties of 
the original site.
The nAChR from the Torpedo electric organ has been shown 
to satisfy all these criteria. There are also reports in
150
the literature dealing with each of these areas for the 
putative insect nAChR (see introduction 1.11). However, 
there is still much work to be done on the insect nAChR to 
fully characterise this protein. The results in this 
thesis go some way towards a better understanding of the 
pharmacology and structure of the insect nAChR and more 
specifically that found in the ganglia of Schistocerca 
gregaria.
4.2 A Comparison of Cholinergic Binding Sites in Insects
125In this study, the binding of ( I) o<bungarotoxin to a
locust ganglionic P2 membrane fraction was compared with
that for ( H) (-) nicotine. This work was inspired by
current work on vertebrate brain nAChR's that are
insensitive to (X bungarotoxin but which bind ( H)(-) 
nicotine with high affinity (see Wonnacott, 1987). The 
type of binding assay developed for this study was
therefore based on that which had previously been used for 
the vertebrate nervous system. ( H ) (-)Nicotine binding to 
vertebrate neural tissue is found to have a fast rate of 
dissociation and therefore requires a method a rapid
separation of the free radioligand from that bound to the 
membranes. This is usually achieved by filtration of the 
samples on glass fibre filters such as Whatman GFC
filters. A modification of this filtration method was
adopted for the binding assays reported here, which arose 
from the work on the purified <X bungarotoxin binding
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protein in this study. When glass fibre filters are
soaked in a solution of 0.3% PEI they are converted from a
negative charge to a positive charge and can therefore be
used in the same way as DE81 cellulose discs for the assay
of solubilised receptors (Bruns e t . a l ., 1983). A
comparison of DE81 discs with PEI treated GFB filters
revealed that the PEI treatment also had the effect of
125reducing background radioactivity for the assay of ( I) 
oL bungarotoxin binding to the purified o<bungarotoxin 
binding component. A similar reduction in background was 
also observed in assays of ( H ) (-)nicotine binding to rat 
brain P2 membranes (Wonnacott, personal communication). 
Therefore this filtration method was used for both the
■ I O C  o
( I) o< bungarotoxin and ( H) (-)nicotine binding assays 
with the locust ganglionic P2 fraction.
Non-specific binding can be a problem in binding assays 
and attempts should be made to reduce the binding as much 
as possible. Three main factors are responsible for non­
specific binding
1) Non-specific binding to sites in the tissue;
2) Free radiolabelled ligand that is not washed out 
of the tissue;
3) Binding of the ligand to some other component in 
the assay such as filters, tubes etc.
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This third point has in effect been dealt with by the use
of PEI treated filters. However, it is worth noting here
that this problem was also encountered with the assay of 
125( I) o( bungarotoxin binding to the P2H fraction and this
was overcome by allowing the eppendorf tubes to stand for
1 hour containing a solution of 1% BSA in PBS followed by
two washes of PBS, before the binding assay was set up.
The problem of unbound radioligand that has not been
washed out of the tissue can obviously be overcome by an
increase in the washing process, but this in turn may
cause greater dissociation of the receptor ligand complex,
thereby decreasing the signal. A balance must therefore
be struck between signal and non-specific backgound. The
most common way to determine binding to non-specific sites
in the tissue is to use a pharmacologically related
displacing ligand. However, when studying a binding site
in a tissue which has not previously been characterised,
there is no way of knowing what is the best related ligand
to use and therefore a better approach is to first
determine the kinetics of binding with non-specific
binding determined by unlabelled ligand followed by a
pharmacological study of the binding site. This is the
approach that has been adopted in this study with
unlabelled (-)nicotine used to determine non-specific 
3
binding for ( H) (-)nicotine and unlabelled <?(bungarotoxin
125used to determine the non-specific binding for ( I) 
OCbungarotoxin.
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Specific binding to the locust ganglionic P2 fraction was
detected for both (3H ) (-)nicotine and (125I)
(X bungarotoxin and was shown to increase linearly with
increasing protein concentration thereby satisfying one of
the criteria for identification of neurotransmitter 
125receptors. ( I) Oi Bungarotoxin binding was shown to
saturate well below 10 nM but this was not the case for
( H ) (-)nicotine binding which did not fully saturate even
at a concentration of 100 nM. However, analysis of the 
3
( H ) (-)nicotine binding data suggested that the binding
would saturate at higher concentrations although this must
be interpreted with caution since Scatchard analysis of
binding data depends on using a concentration range giving
10-90% occupancy of the binding sites. The results
calculated for the Kd and Bmax for ( H) (-) nicotine and 
125( I) oc bungarotoxin binding to the locust ganglionic P2
fraction were compared with values for rat brain P2
membranes obtained in a parallel study (MacAllan et. a l .,
1988) and these are shown in table 14. The results
125obtained for ( I) cX bungarotoxin binding to the locust
ganglionic P2 fraction are in good agreement with the
previously published Kd and Bmax values for other insects
(see table 1 and Sattelle, 1986). Moreover, the Kd 
125
for ( I) oi bungarotoxin binding to the locust ganglionic 
P2 fraction was very similar to that obtained for the rat
brain P2 membranes. However, a large difference was
observed in the calculated Kd for (3h )(-)nicotine binding
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to the two tissues, with the locust ganglionic P2 fraction
exhibiting a much lower affinity, although it is important
to remember that this value was calculated from a
concentration range that was not fully saturating (see
above). Bmax values for both radioligands binding to the
locust ganglionic P2 fraction were an order of magnitude
greater than those observed for the rat brain P2 membrane
fraction. It is interesting to note that the Bmax values 
3
for ( H) (-) nicotine binding were 2-4 times more than for 
125( I) €>(. bungarotoxin binding in each tissue.
In rat brain, an endogenous inhibitor of ( H ) (-)nicotine
binding has been identified which has been shown to affect
the Kd for the binding of this ligand (Sershen e t . a l .,
1984; Perry e t . a l ., 1986). The nature of this inhibitor
has not yet been properly established. To check if a
similar inhibitor is present in locust ganglia, the P2
fraction was washed with either buffer or water. However,
neither treatment was found to increase the affinity of
( H )(— ) nicotine binding. It is therefore assumed that
there is no endogenous inhibitor for the ( H ) (-)nicotine
binding site in the locust ganglia or if there is, the
washing procedure tried does not remove it. An endogenous 
125
inhibitor of ( I) oLbungarotoxin binding has however 
been identified in homogenates of Locusta migratoria 
ganglia (Breer, unpublished). This inhibitor can be 
removed by washing the membrane homogenate which results
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12 5in an increase in ( I) OC bungarotoxin binding.
Furthermore, the inhibitor has been purified and when
added back to the washed membrane preparation inhibits
( ^ ”*1) 0( bungarotoxin binding. In this study, binding
125experiments with ( I) oi bungarotoxin were performed on a
membrane fraction that had been centrifuged and
resuspended in fresh buffer and therefore an endogenous
125inhibitor of ( I ) oi bungarotoxin binding may also be 
present in this tissue but it is likely that it would be 
washed out by the membrane fractionation procedure. The 
effect on the binding of further washing of the membrane 
fraction was not tested here.
Having identified differences in the binding sites for
3 125( H ) (-)nicotine and ( I) 0C bungarotoxin in locust
ganglia, it was necessary to further characterise these
sites by determining IC5q values for the inhibition of
each radioligand by a range of other cholinergic ligands.
However, values are dependent on the concentration of
radioligand used in the assay. It is therefore important
to work at a radioligand concentration close to the Kd to
get as good an estimate as possible of the IC5Q for the
displacing ligand. In practice this is not always
3
possible and in this study a concentration of 50 nM ( H)
(-)nicotine was used (cost of the radioligand precluded
the use of higher concentrations) which is less than half 
the Kd of 130 nM. In contrast, the concentration of
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125( I) 0< bungarotoxin used for the inhibition studies was 
1 nM compared with a Kd of 0.8 nM. It is, however, 
possible to make a direct comparison of these inhibition 
studies by eliminating the effect of the concentration of 
radioligand by converting the IC 5q values to inhibition 
constants (Ki) using the formula
Ki = IC5Q/(1 + L/Kd)
where L is the radioligand concentration and Kd is the 
dissociation constant for that radioligand (Cheng and 
Prussoff, 1973). Therefore Ki values have been used 
instead of IC^q values in this study.
Another requirement to be considered in inhibition studies
is that the receptor binding site concentration should be
less than 10% of the Kd for the radioligand (Jacobs e t .
a l ., 1975). In this study, the average receptor site
3concentration for ( H ) (-)nicotine binding in the
inhibition studies was 1 nM and was therefore well below
310% of the Kd for ( H) (-) nicotine binding. However, to
125get a reasonable signal for ( I) ck bungarotoxin binding, 
a receptor concentration of 0.32 nM was used which may 
result in the Ki values deviating slightly from the true 
value. It is very important when comparing inhibition 
results from different studies to take these factors of 




The pharmacology of the binding of ( H ) (-)nicotine and 
125( I) o(bungarotoxin to the locust ganglionic P2 membrane
fraction was studied using several cholinergic ligands,
and in particular, two novel toxins, MLA and ( + )anatoxin-a
(the naturally occuring enantiomer). MLA has previously
been shown to inhibit ( H) oL bungarotoxin binding to a
membrane fraction of housefly heads with a Ki of 2.5 x
10 1(^ M and it is known to be a potent insecticide
(Jennings e t . a l ., 1986). ( + )Anatoxin-a is a potent
agonist of the vertebrate muscle nAChR (Spivak et. a l . ,
1983 ; Spivak e t . a l ., 1983) closely resembling channel
properties evoked by ACh (Spivak et. a l ., 1983). This
toxin has been shown to have a much lower affinity for the
muscarinic binding site of rat brain (Aronstam and Witkop
1981). (+)Anatoxin-a and MLA were found to be equally
125potent inhibitors of ( I) oC bungarotoxin binding to the
locust ganglionic P2 fraction. The classical nicotinic
antagonist Dty$E was found to be slightly more effective at
this site, than both of these toxins, whereas, (-)nicotine
was slightly less effective. Neither (+)nicotine or (-)
125anatoxin-a were very effective inhibitors of ( I)
Oi bungarotoxin binding to this tissue. Only (-) and ( + )
nicotine were found to effectively inhibit the binding of
( H ) (-)nicotine to the locust ganglionic P2 fraction,
although the stereospecificity for the (-)enantiomer was
12 5low compared to that for the inhibition of ( I)
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oL bungarotoxin. In contrast, the stereospecificity for 
(-) nicotine inhibition of the two radiolabelled ligands
in rat brain P2 membranes was found to be greater against
3 125( H ) (-)nicotine binding than ( I) (X bungarotoxin binding
(Wonnacott 1986). All of the other cholinergic ligands
tested for their ability to inhibit ( H ) (-)nicotine
binding to the locust ganglionic P2 fraction were found to
be virtually ineffective.
The rank order of potency of cholinergic ligands
3 125inhibiting ( H) (-) nicotine and ( I ) Cxi bungarotoxin
binding to the locust ganglionic P2 fraction and rat brain
P2 membranes is shown in table 15. It is clear that the
125order of potency for the inhibition of ( I) 
Oi bungarotoxin binding in these two tissues is 
essentially similar with the exception of DHySE, which is 
the most effective inhibitor in locust ganglia but is only
moderately effective in rat brain. The order is also very
3 125similar for the inhibition of ( H ) (-)nicotine and ( I)
(X bungarotoxin binding in rat brain with the exception of
125MLA, which is the most potent at the ( I ) oC bungarotoxin
binding site but is only moderately effective at the 
3
( H ) (-)nicotine binding site. MLA is obviously a good
125
probe for neuronal ( I) CX bungarotoxin binding sites
125since it is not an effective inhibitor of ( I) 
cX bungarotoxin binding to the Torpedo nAChR (MacAllan e t . 
a l », 1988). Moreover, MLA shows a specificity only
previously seen with the snake venom ottoxins.
159
125The ( I) Ot bungarotoxin binding site in locust ganglia
certainly satisfies the third criterion for the
identification of a neurotransmitter receptor whereas the
( H ) (-)nicotine binding site displayed no significant
cholinergic pharmacology. Therefore, from these binding
studies, it is concluded that in locust ganglia there is 
125an ( I ) oi bungarotoxin binding site which shares 
pharmacological specificity with both vertebrate neuronal 
and peripheral nAChR's, and there is also a specific 
( H ) (-)nicotine binding site, the pharmacology of which 
appears to be non-cholinergic at this stage. However, it 
is interesting to note that early studies on the binding
3
of ( H) (-)nicotine to vertebrate brain tissue suggested
3
that there were ( H ) (-)nicotine binding sites which were
non-cholinergic based on the inability of nicotinic and
muscarinic ligands to inhibit the binding (Abood et . a l . ,
1980; Sershen e t . a l ., 1981). More detailed studies on
the binding of ( H ) (-)nicotine to vertebrate brain
membrane preparations revealed that there are cholinergic 
3
( H ) (-)nicotine binding sites present showing strong 
sensitivity to many nicotinic ligands and in particular 
those that are agonists (see Wonnacott, 1987 for review).
A previous study on ( H ) (-)nicotine binding to a membrane 
fraction from housefly heads and the nerve cord of the 
American and Madagascar cockroach suggested the presence 
of high affinity nicotine binding sites in these tissues
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with K d ' s of 3, 1.1 and 1.5 yu M respectively (Aziz and 
Eldefrawi, 1973). These binding sites had low affinity
for ACh, determined by inhibition studies, but exhibited 
both nicotinic and muscarinic pharmacology. The authors 
therefore concluded that this ( H)nicotine binding site in 
insect membrane tissue was the same as the 
(JH)decamethonium binding site identified in soluble 
extracts of insect nervous tissue (i.e. the mixed affinity 
site : see introduction section 1.11.1).
In a further attempt to characterise the identity of the
3
( H ) (-)nicotine binding site, in the locust ganglionic P2
3
fraction, as a neuronal nAChR, ( H)MCC was tested for its
3
ability to bind to these sites. ( H)MCC has been shown to 
bind to high affinity binding sites in rat brain which can 
be potently inhibited by nicotinic ligands but only poorly 
inhibited by muscarinic ligands (Boksa and Quirion, 1987; 
Abood and Grassi, 1986). Moreover, the Kd and Bmax for 
this binding were found to be very similar to those for 
( H ) (-)nicotine binding to rat brain tissue and it is 
generally accepted that they both bind to the same site. 
In this study, although the binding of ( H)MCC to the 
locust ganglionic P2 fraction could be shown to increase 
with increasing concentration of the ligand, this binding 
could not be displaced by nicotine or by any other 
cholinergic ligand tested and the binding was therefore 
determined to be non-specific. However, ( H)MCC would be
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expected to bind to the (Xbungarotoxin binding site
125
since (-)nicotine is a good inhibitor of ( I)
(X bungarotoxin binding. No inhibition of ( H)MCC binding
by oC bungarotoxin could be detected and this may be
explained if higher concentrations of ( H)MCC are needed
to get detectable binding to this site. Indeed at
relatively high concentrations, of ( H)MCC (75 nM and 100
nM), small levels of specific binding could be determined
with (-)nicotine as the displacing ligand and this
specific binding may represent binding of ( H)MCC to the
oc bungarotoxin binding site. It would be interesting to
investigate the effects of unlabelled MCC on the binding 
125of ( I ) ex' bungarotoxin binding and calculate a Ki value 
for it, although unlabelled MCC is not available at 
present.
Therefore, the nature and specificity of the high affinity 
( H ) (-)nicotine binding site in locust ganglia is still 
unclear and further work on this site will be necessary to 
demonstrate its significance and whether it represents 
part of a true nAChR. However, at present, according to 
the criteria for identification of neurotransmitter 
receptors, it remains just a specific binding site.
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4.3 Purification and Analysis of the Locust (XBungarotoxin 
Binding Protein
Having identified pharmacologically significant binding 
sites for a ligand, the next step is to purify the
receptor protein. This has been attempted by several 
groups for the insect CX bungarotoxin binding site (see 
introduction 1.11.4) but there is still controversy over 
the size and numbers of receptor subunits. Therefore
further purification and analysis of the c*£ bungarotoxin 
binding protein is required.
12 5In this study, an initial analysis of the level of ( I) 
o( bungarotoxin binding sites present in the heads of the 
five instar stages was compared with that for the adult 
head, in an attempt to identify a stage which was
particularly rich in this binding site. It was clear from 
the results that although the level of binding per head 
increased with each stage of development, the level of 
binding per mg of protein was relatively constant 
throughout development. The choice of material for the 
purification of the oCbungarotoxin binding protein was 
therefore the adult insect ganglion.
Previous work in this laboratory (unpublished) suggested
that the detergent Lubrol PX was the best detergent to use 
for the solubilisation of the locust ganglia cKbungarotoxin 
binding protein. This detergent is a mild non-ionic
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detergent which was used in the isolation of the chick 
optic lobe cxbungarotoxin binding protein (Conti-Tronconi 
e t . a l ., 1985). In the case of locust ganglia, maximum
I O C
( I )  (X bungarotoxin binding activity was solubilised 
from the membrane with a Lubrol PX concentration of 3% 
(w/v). It is interesting to note here that ( H)(-) 
nicotine did not bind to this detergent extract, and this 
might be explained by the ( H) (-) nicot ine binding site 
being very labile when extracted from the membrane, as has 
been noticed with the rat brain high affinity nicotine 
site (Wonnacott, personal communication).
Purification of the vertebrate peripheral oCbungarotoxin 
binding protein has been accomplished by the use of 
affinity columns with immobilised Naja Naja toxin rather 
than o( bungarotoxin, since the binding to Naja Naja toxin 
is more reversible than to o( bungarotoxin for these 
vertebrate receptors. However, OCbungarotoxin affinity 
columns have proved useful for the isolation of neuronal 
(X bungarotoxin binding proteins and in particular for the 
insect o{bungarotoxin binding protein since the affinity 
of these sites is much lower than that of the Torpedo or 
vertebrate muscle nAChR. In this study a method of 
recirculation of benzoquinonium through the affinity 
column and a DE52 ion exchange column was used to elute 
the oCbungarotoxin binding protein bound to the affinity 
column. This method circumvented the need to dialyse away
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the eluting ligand. Benzoquinonium was chosen as the
eluting ligand because it is coloured red and is therefore
easy to observe when applying it to the recirculation
system and when washing it out. It is also a good
125inhibitor of ( i) oC bungarotoxin binding in locust
ganglia (Filbin e t . a l ., 1983). The quantity of protein
purified from 100 ganglia was very small and certainly
below the detection limits of any of the well known
protein assay methods. However, an ultrasensitive protein
assay at the nanogram level using colloidal gold has
recently been reported (Stoscheck, 1987) which may prove
useful in future studies of this protein. Estimates of
the amount of protein purified were made from the results 
125of ( I) o<bungarotoxin binding and were around 1 j \g per 
100 ganglia.
Enough protein was purified from about 25 locust ganglia 
to analyse by SDS-PAGE using a silver staining procedure. 
In these experiments, a predominant band with a Mr of 
49,000 was found to be consistently present in all the 
preparations. How then does this protein relate to the 
Oi bungarotoxin binding protein purified from other 
insects? A similar protein has been purified from another 
species of locust, Locusta migratoria, and from the 
cockroach Periplaneta americana, both of which appear to 
be composed of one type of subunit with a Mr of 65,000 
(see Breer and Sattelle, 1987). This single polypeptide
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has been proposed to form a homo-oligomer structure (Breer 
e t . a l ., 1985). It is clear from sequence analysis that
the four genes coding for the subunits of the Torpedo 
nAChR have evolved from two and initially one ancestral 
gene (see introduction section 1.8.1, also see Raftery e t . 
a l ., 1980) and it has been proposed that the locust nAChR 
single Mr 65,000 polypeptide may be coded for by the 
ancestral gene (Breer et. a l ., 1985). In this study on
the Schistocerca gregaria c<bungarotoxin binding protein, 
several of the purified preparations were observed to 
contain an additional band at Mr 66,000. In these 
preparations, it is unclear whether this additional band 
is part of the (Xbungarotoxin binding protein or whether 
it is another protein copurifying on the affinity column. 
The o( bungarotoxin binding protein from Locusta migratoria 
was also purified in this study, and was found to have a 
single subunit of Mr 51,000. Another insect 
OC bungarotoxin binding protein has been purified from 
housefly heads and has been shown to consist of two types 
of subunits with Mr's 42,000 and 25,000 (March e t . a l ., 
1982). The smaller of these two bands is thought possibly 
to be due to proteolysis.
A possible reason for the differences between these 
results from different groups is that a different 
detergent is used in each study. In this study Lubrol PX 
was chosen as detergent whereas Triton X-100 was used in
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the case of housefly heads (March e t . a l ., 1982) and
sodium deoxycholate was used for Locusta migratoria (Breer 
e t . a l ., 1985). In the case of the chick optic lobe
OC bungarotoxin binding protein, the detergent Lubrol PX 
was found to solubilise a component with a sedimentation 
coefficient of 9.IS compared to 12S for the related 
component from other brain regions (Norman e t . a l ., 1982).
However, when Triton X-100 was used in place of Lubrol PX 
the sedimentation coefficient changed to the 12S value. 
These differences were attributed to different protein 
oligomers being formed in the initial extraction procedure 
rather than to the size of the receptor/detergent 
miscelles. However, SDS-PAGE analysis of these two 
preparations yielded essentially similar results with the 
major polypeptide at Mr 54,000 and a minor band at Mr
51,000, but in the triton X-100 purified samples an 
additional band at Mr 47,000 was present which disappeared 
with progressive purification, without affecting receptor 
activity, and was concluded not to be an integral part of 
the nAChR. Therefore it is unlikely that the use of 
different detergents in these insect preparations is the 
cause of different Mr results on SDS-PAGE and a more 
plausible reason for these differences could be due to the 
presence of proteolytic activity during the purification 
procedure, a situation observed in the early attempts to 
purify vertebrate nAChR's (Conti-Tronconi and Raftery,
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1982). The Torpedo nAChR is now known to be a pentamer of 
four different types of subunit, although there was 
considerable controversy over the subunit composition in 
the early days of study (Conti-Tronconi and Raftery, 
1982). It is now clear that proteolysis has a significant 
effect on the subunit pattern of the Torpedo receptor with 
the CX subunit being more resistant to proteolysis than 
the p> , if or 8  subunits, and it has been shown that 
inclusion of potent protease inhibitors allows the 
isolation of the receptor protein with all four intact 
subunits (Conti-Tronconi and Raftery, 1982). A similar 
situation was encountered in the attempts to purify the 
chick optic lobe 0( bungarotoxin binding protein (Conti- 
Tronconi et . a l ., 1985 ; Norman e t . a l ., 1982).
Furthermore, it has been demonstrated that proteolysis 
does not necessarily mean that the physical and functional 
properties of the receptor protein are affected since 
extensive proteolysis of the receptor protein by papain or 
trypsin does not significantly alter the binding capacity 
for OC bungarotoxin, cholinergic ligands or antibodies, 
only slightly affects the sedimentation behaviour and the 
receptor protein can still be functionally reconstituted 
into lipid bilayer membranes (Conti-Tronconi and Raftery,
1982). However, only when the protein is denatured in SDS 
and subjected to electrophoresis does the damage become 
evident. Therefore, it is clear that the proteolytic 
damage can be in the form of nicks in the polypeptide
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chain and the protein still holds together with a minimum 
degree of fragmentation.
With this in mind, it is possible that the polypeptide of 
Mr 49,000 purified from the locust ganglia in this study 
is a proteolysis product of the same protein purified by 
Breer. Similarly, the polypeptide of Mr 42,000 purified 
from housefly heads may also represent a proteolysis 
product of some larger protein and it is interesting to 
note here, that long storage of the Schistocerca 
qregaria CX bungarotoxin binding protein at 4°C, in this 
study, resulted in a change in Mr of the predominant band 
from 49,000 to 43,000. To try to determine whether 
proteolysis was the cause of the difference in Mr between 
the Schistocerca qregaria and Locusta migratoria 
OC bungarotoxin binding protein, several protease 
inhibitors used in the purification of vertebrate receptor 
proteins were included in the purification buffers in this 
study. However, no indication of protease inhibition was 
detected since the Mr of the predominant band remained at
49,000. The nature and specificity of proteases in the 
insect nervous system has been an area of little if any 
research and therefore there is no reason to assume that 
protease inhibitors active against vertebrate proteases 
will also be active against insect proteases.
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Having purified the insect OC bungarotoxin binding
protein, the question then arises of whether this protein 
represents a functional nAChR. This has in fact been 
partly answered by the reconstitution of the otbungaro toxin 
binding protein from Locusta migratoria into artificial 
lipid bilayers, resulting in the formation of functional 
nAChR channels which were shown to respond to the 
cholinergic agonists carbamylcholine and suberyldicholine 
by a marked increase of conductance and this could be 
blocked by the nicotinic antagonist d-tubocurarine (Hanke 
and Breer, 1986). Moreover, single channel recording in 
physiological saline gave a conductance of 70-80 pS with a 
channel lifetime of a few millseconds. The Mr 65,000 
polypeptide of the Locusta migratoria o C bungarotoxin 
binding protein has been eluted from denaturing gels and 
reconstituted into artificial lipid bi-layers resulting in 
functional nAChR channels (Breer, 1988) and therefore it 
would seem like this polypeptide alone can form a 
functional nAChR channel. However, the effect of 
(X bungarotoxin as an antagonist in these experiments was 
not reported. The rat brain 0(4 clone when expressed in 
oocytes directs the synthesis of a polypeptide chain which 
confers weak nicotinic responses to the oocyte membrane 
(Boulter et. a l ., 1987) and therefore it may be that
nicotinic responses can be produced by a single type of 
subunit (i.e. the ligand binding subunit).
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Therefore, all the criteria for the identification of the 
insect OCbungarotoxin binding protein as a functional 
neurotransmitter receptor have been satisfied, but it is 
clear that controversy still surrounds the true molecular 
structure of this nAChR.
It seems likely that, as in the case of vertebrate brain, 
there may be heterogeneity of nAChR's in insect C N S . This 
hypothesis has recently been supported by the 
identification of presynaptic or extrasynaptic nAChR's in 
the membrane of a cholinergic axon in the cockroach first 
instar (Blagburn and Sattelle, 1987). The sensitivity of 
this axon of the lateral filiform hair sensory neurone to 
iontophoretically applied carbamylcholine was found to be 
similar to that of the dendritic regions of giant 
interneurone 3 (known to contain postsynaptic nAChR's). 
Nicotine was shown to mimick the carbamylcholine responses 
in these two neurones and both the nicotine and 
carbamylcholine evoked response in both neurones were
_ 5 _ ^
blocked by 10 M mecamylamine and 10 M d-tubocurarine but 
not by muscarinic antagonists. It has been suggested that 
the nAChR’s on the presynaptic axon may represent 
nicotinic autoreceptors although direct evidence to 
support this has not yet been obtained.
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4.4 Affinity Labelling of the Locust nAChR
Affinity labelling of neurotransmitter receptors is a 
useful technique to identify the ligand binding subunit 
and the actual location of the ligand binding site within 
that subunit. There are two types of affinity labelling 
regularly used in the study of neurotransmitter receptors, 
namely photoaffinity labelling and affinity labelling with 
alkylating compounds. Photoaffinity labelling requires 
the use of a photoactivatable ligand for the receptor, 
such as flunitrazepam, which has been used for the study 
of the benzodiazepine binding site of the locust ganglia 
GABA-receptor complex (Robinson e t . a l ., 1986). The other 
type of affinity labelling has been used for the study of 
the nAChR and involves the compound ( h )MBTA which has an 
affinity for the cholinergic binding site and also 
contains a sulphydryl alkylating group which will alkylate 
reduced cysteine residues. In this way the o£subunit of 
the Torpedo and vertebrate muscle nAChR have been 
identified as the ligand binding subunit and the cysteine 
residues at positions 192 and 193 (Torpedo o^subunit) 
have been located at the ligand binding site of the 
protein (Kao e t . a l . 1984). A previous report, from
this laboratory on the (Ybungarotoxin binding protein
3
in Schistocerca gregaria indicated that ( H )MBTA 
labelled a polypeptide of Mr 58,000 in a P2
172
membrane fraction (Filbin et a l ., 1983) whereas a report 
on the housefly head CXbungarotoxin binding protein 
demonstrated that ( H)MBTA labelled a polypeptide of
42,000 (March et a l ., 1982). In this study, a polypeptide 
of Mr 49,000 in the P2 membrane fraction was labelled with 
(3H)MBTA. This (3H)MBTA labelled polypeptide corresponds 
exactly to the Mr of the purified (Xbungarotoxin binding 
protein from locust ganglia in this report and it is 
likely that they are the same protein. The difference 
between the Mr for the labelled protein in this study and 
that reported by Filbin e t . a l . (1983) may be attributable 
to differences in SDS-PAGE techniques. How then, do these 
affinity labelling results for insects compare to studies 
on vertebrate brain? ( H)MBTA has been shown to 
label a subunit of an (Xbungarotoxin insensitive nAChR in 
chick brain with a Mr of 59,000 (Whiting and Lindstrom, 
1987a). However, in the study of the vertebrate brain 
oC bungarotoxin binding protein, BACh was used as the 
affinity ligand in place of ( H)MBTA. In chick brain, a 
subunit polypeptide of Mr 56,000 was labelled with this 
ligand (Conti-Tronconi e t . a l ., 1985) and this
corresponds well with the CxLbungarotoxin binding protein 
from rat brain in which the Mr 55,000 subunit was labelled 
(Kemp et . a l ., 1985).
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4.5 Cross-Reactivity of the Locust QCBungarotoxin Binding 
Protein with Other nAChR's
A commonly used approach to the study of nAChR's is to
look for crossreactivity between receptors from different
species. An initial study with an anti Torpedo nAChR
antiserum demonstrated that there was no crossreactivity
between the Torpedo nAChR and the detergent solubilised
OC bungarotoxin binding protein from housefly heads
(Eldefrawi and Eldefrawi, 1980). More recently however,
Mab's against the Torpedo nAChR have shown that there is
crossreactivity between this receptor and the putative
nAChR in insects (see introduction section 1.11.6). In
the present study, an antiserum against the purified
Torpedo nAChR was found to precipitate a small amount of 
125
( I) 0Cbungarotoxin binding activity from the detergent
extract suggesting a low level of crossreactivity. It is
not surprising that only low crossreactivity was detected
with this antiserum since it is known that the
crossreactivity between the Torpedo and vertebrate muscle
nAChR can be low (Lindstrom et . a l ., 1979). Mab's raised
against the Torpedo nAChR and vertebrate brain high
125affinity nicotine sites were unable to precipitate ( I) 
OC bungarotoxin binding activity from the detergent 
extract in this study. However, since Mab's are directed 
against only one epitope of a protein it is less common to 
find crossreactivity with a Mab than with an antiserum and 
many more Mab's would have to be tested to find one that 
does crossreact.
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4,6 The application of Molecular Biology to the Study of 
the Insect nAChR
It is becoming increasingly clear that the techniques of 
molecular biology are a valuable asset to the neurochemist 
for the study of neurotransmitter receptors and use of 
these techniques has been exploited for the study of the 
Torpedo and vertebrate muscle nAChR's and more recently 
for the study of vertebrate neuronal nAChR's (see 
introduction sections 1.8, 1.9 and 1.10.5). Molecular
biology methodology is now also being applied to the study 
of the insect nAChR (see introduction section 1.11.8).
Before the genes encoding the receptor protein can be 
isolated, a suitable probe is required and in the case of 
the Torpedo nAChR this was obtained by sequencing the N 
terminus of each of the receptor subunits. An
oligonucleotide probe was then constructed corresponding 
to the N terminal sequence and used to probe for the 
corresponding gene. Therefore, attempts were made in this 
present study to obtain N terminal sequence for the 
purified oC bungarotoxin binding protein. However, for 
each attempt to get sequence data at least one thousand 
ganglia are required as starting material and therefore 
the cost of several attempts was prohibitive. The one 
attempt that was made resulted in the protein having a 
blocked N terminal and no further attempts were made.
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In collaboration with John Marshall at the MRC Molecular 
Neurobiology Unit, Cambridge, initial attempts were made 
to express the locust ganglia Ot bungarotoxin binding 
protein by injecting poly A+ mRNA from locust ganglia into
the Xenopus oocyte expression system. Significant levels
12 5of ( I) DC bungarotoxin binding sites were detected in
detergent extracts of these injected oocytes, comparable
to oocytes that had been injected with Torpedo poly A+
mRNA. Therefore it was concluded that the locust ganglia
was a good source of receptor specific mRNA, from which a
cDNA library could be constructed and used to isolate
clones coding for the locust ganglia nAChR. Initial
results of this cloning work have now been reported by
Marshall e t . a l ., (1988a). During this early work on the
expression in oocytes, the group of Breer also reported
125the expression of ( I) OC  bungarotoxin binding sites in 
oocytes, directed by poly A+ mRNA from Locusta migratoria 
ganglia (Breer and Benke, 1985). This was followed by a 
publication reporting the immunoprecipitation of 
polypeptides, synthesised from the poly A+ mRNA in 
oocytes, with a monospecific antiserum to the Locusta 
migratoria purified OC bungarotoxin binding protein. The 
only precipitated polypeptide was shown to have a Mr of
65,000 corresponding to the purified OC bungarotoxin 
binding protein (Breer and Benke, 1986).
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As mentioned above, cDNA clones have now been isolated 
which are thought to code for subunits of the insect nAChR 
(see introduction section 1.11.8). In the case of the 
locust, Schistocerca gregaria, a genomic clone was 
initially isolated using a chick brain nAChR cDNA probe 
(Marshall et. a l ., 1988a) and a 400 base pair fragment of
this clone was subsequently used to screen a X g t  10 cDNA 
library from locust (Marshall et. a l ., 1988b) resulting in 
the isolation of two non-identical cDNA clones named ARL1 
and ARL2. One of these clones has been proposed to 
correspond to an alpha-like polypeptide and the other a 
non-alpha polypeptide of a nAChR. Part of the sequence of 
the non-alpha clone corresponds to a highly conserved 
region found in all nAChR subunits and also in other ion 
channel receptors (see introduction section 1.12). This 
sequence is identical to a sequence found in the fruitfly 
non-alpha ARD clone (Hermans-Borgmeyer e t . a l ., 1986) and 
is able to form a loop structure linked by the two 
cysteine residues (see introduction section 1.12). Both 
the ARD clone and locust non- oC clone show considerable 
homology over this region to another isolated Drosophila 
clone, the ALS clone which is thought to be an oC-like 
subunit of the insect nAChR (see introduction section 1.12 
and figure 8).
In this study, a peptide corresponding to this cysteine 
loop region was synthesised with modified cysteine
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residues so that the synthesised peptide would not be 
disulphide linked. However, it is likely that the peptide 
would adopt a conformation that is similar to the
by the proline residue whether the two cysteines are 
linked or not. It was assumed that this unlinked form of 
the peptide would still be able to elicit an antibody 
response which would recognise the native insect nAChR 
since a recent report has shown that a non-disulphide 
linked peptide corresponding to the sequence 125-147 
(encompassing the cysteine loop region) of the human muscle 
OL subunit was able to generate an antiserum with 
myasthenic activity (McCormack e t . al ., 1987) implying
crossreactivity with the native receptor.
The antiserum raised against the synthetic peptide in this
125study was not able to precipitate ( I) oC bungarotoxin 
binding activity from the detergent extract of the locust 
ganglionic P2 fraction. It did however identify two 
specific bands in Western blots of SDS-PAGE using the 
locust ganglionic P2 fraction as antigen. These bands 
correspond to Mr's of 49,000 and 60,000 with the 49,000 
band being the strongest. This anti serum was also shown 
to react with the purified (Xbungarotoxin binding protein 
in a Western blot. The polypeptide of Mr 49,000 which
3
binds 0C bungarotoxin and ( H)MBTA is by analogy to the 
vertebrate receptors an (X-like subunit. However, the
disulphide linked form since a loop is induced
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peptide sequence was derived from a proposed non-o( subunit 
and may therefore indicate a high degree of homology 
between these two identified polypeptides over this 
cysteine loop region. The faint band at Mr 60,000 
observed in the Western blot of the P2 fraction may be the 
protein encoded by the non-cX clone and its low abundance 
compared to the band at Mr 49,000 may be due to effect of 
proteolysis as discussed earlier (section 4.3).
Alternatively, the band at Mr 60,000 may be the same 
protein as the Mr 49,000 band which has not been 
proteolysed to the same extent or may represent a subunit 
of a different ion channel receptor. It is likely that 
antibodies to this synthetic peptide could cross react 
with polypeptide chains of other ion channel receptors 
since it is becoming clear that all ion channel receptor 
proteins belong to a super family of proteins with
considerable sequence homology in their polypeptides
particularly in the cys loop region (see introduction
section 1.12).
A final piece of evidence to back up the proposal that the 
non-CX clone encodes a subunit of the locust nAChR came 
from antibody studies. An antiserum that had been raised 
to the purified (X bungarotoxin binding protein from 
Schistocerca gregaria was shown to recognise the synthetic 
peptide indicating crossreactivity of the peptide with the 
ot bungarotoxin binding component.
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More work on these ARL1 and ARL2 clones is currently 
underway and the full coding sequences will soon be known. 
Recently, it has been reported that these two clones have 
been injected into Xenopus oocytes resulting in the 
appearance of electrophysiological responses to bath- 
applied nicotine (Marshall e t . a l ., 1988b).
4.7 Future Research on the Insect nAChR
This thesis has reported improved characterisation of the 
locust nAChR. There is still a large amount of work to be 
tackled in this field however and future research is 
likely to be concentrated more towards the use of 
molecular biology to characterise the receptor. However, 
it is essential to back up the results obtained by 
molecular biology with those from biochemical and 
physiological studies.
Initial studies show extensive homology of the insect 
receptor with the vertebrate receptors and in particular 
the vertebrate neuronal nAChR's. It is possible that 
insect ganglia may also contain heterogeneous populations 
of nAChR's and therefore more detailed comparisons of 
vertebrate and invertebrate receptors are required. This 
may be of interest to the insecticide companies if 
differences are identified which could be used in rational 
design programmes for the synthesis of new insecticides.
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Computer modelling is likely to make a major impact on our 
knowledge of both the vertebrate and insect nAChR's and 
once the full tertiary structure for the Torpedo nAChR is 
known, it should not be long before computer generated 
three dimentional models of the other nAChR's, including 
the insect nAChR, will be available.
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CONCLUDING COMMENTS
(1) This study has made use of a-bungarotoxin as a probe of the nAChR. What 
evidence is there to suggest that the a-bungarotoxin binding protein in locust ganglia 
is a functional nAChR? There is no direct evidence for the locust Schistocerca 
gregaria and therefore a comparison has had to be made with other insect species. An 
a-bungarotoxin binding protein purified from another species of locust, Locusta 
migratoria. has been reconstituted into planar lipid bilayer membranes (Hanke and 
Breer, 1986). Functional ion channels have been identified in these membranes 
which respond to suberyl dicholine and carbamyl choline. However, there was no 
report on whether or not a-bungarotoxin could block these agonist evoked responses. 
Electrophysiological studies on the cockroach CNS have demonstrated that 
a-bungarotoxin can block synaptic transmission (Sattelle ai. al-, 1983) and nAChR 
responses to iontophoretically applied nicotinic agonists (Harrow and Sattelle,
1983) .
(2) SDS-PAGE analysis of the a-bungarotoxin binding protein, purified from 
Schistocerca gregaria ganglia, demonstrated that a polypeptide of Mr 49,000 was 
consistently present in different samples. However, in three of the samples an 
additional polypeptide of Mr 66,000 was also present. A previous study on the 
Schistocerca greoaria a-bunaarotoxin binding protein suggested the presence of 
polypeptides with Mr 60,000, 41,000 and 25,000 (Filbin at. aL, 1983) but it is 
not clear how these polypeptides relate to the results in this study. The 
a-bungarotoxin binding protein from Locusta mioratoria. has been shown to consist 
of a predominant polypeptide with Mr 65,000 (Breer al. al-, 1985). It is not clear 
whether the Schistocerca gregaria Mr 49,000 polypeptide is a proteolytic product of 
the Mr 66,000 polypeptide that is occasionally present in these purified samples or 
if they are different subunits of the a-bungarotoxin binding protein. If proteolysis
1 8 2
is the reason, then the a-bungarotoxin binding protein from these two species of 
locust may be very similar. It has been proposed that the a-bungarotoxin binding 
protein from Locusta migratoria is a homo-oligomer of the Mr 65,000 polypeptide 
(Breer el- a l,  1985). However, it is possible that the a-bungarotoxin binding 
protein from both of these species of locust contain other subunits in addition to the 
predominant polypeptide, and their absence on denaturing gels could be due to 
proteolysis. Putative nAChR a-iike and non-a-iike subunit genes have been isolated 
from locust, Schistocerca gregaria (Marshall el- al-, 1988), and fruitfly, 
Drosophila melanogaster (Hermans-Borgmeyer el- al., 1986; Bossy el-Ql-, 1988), 
thereby lending support to the idea that the a-bungarotoxin binding protein consists 
of more than one subunit type.
(3) Four antisera were raised to a synthetic peptide corresponding to the cysteine 
loop region from the non-a-like gene of Schistocerca gregaria (Marshall £i. al., 
1988). All four antisera were strongly reactive against the peptide but only one was 
found to have low crossreactivity with specific proteins of the ganglionic P2 fraction 
on Western blots (a strong band at Mr 49,000 and a weaker band at Mr 60,000). 
Very low crossreactivity of this antiserum with the purified a-bungarotoxin binding 
protein was also observed. The reason for the low crossreativity may be explained 
by differences in the conformation of the immunising peptide and the conformation of 
the proteins on the Western blots.
(4) A critical experiment in this study was the identification of a polypeptide of the 
ganglionic P2 fraction that was specifically labelled with [3H]MBTA to a greater 
extent than any other. The Mr of this polypeptide (Mr 49,000) was the same as the 
Mr of the major polypeptide of the purified a-bungarotoxin binding protein and the 
stronger reacting of the two polypeptides identified with the antipeptide antiserum.
1 8 3
However, there was a high background labelling in these experiments and it is 
possible that other polypeptides were also specifically labelled. A previous study on 
Schistocerca oregaria suggested that a polypeptide of Mr 58,000 was labelled with 
[3H]MBTA (Filbin £l. al-, 1983). There have been no reports of affinity labelling 
experiments for Locusta migratoria.
(5) [3H](-)Nicotine would be expected to bind to the a-bungarotoxin binding 
protein in Schistocerca gregaria ganglia based on the calculated Ki value for the 
inhibition of [123l]a-bungarotoxin binding by (-)nicotine. The [3H](-)nicotine 
binding in this study was determined non-cholinergic suggesting that it was not 
binding to the same site as [125l]a-bungarotoxin. However, it is possible that the 
[3H](-)nicotine binding to this tissue preparation was largely non-specific and 
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Phosphate Buffers
TABLE B.tO Preparation of 0.1 m 
Potassium Phosphate Buffer at 25°C
Volume of 1 m Volume of 1 m













Data from Green (1933).
TABLE B.11 Preparation of 0.1 m
Sodium Phosphate Buffer at 25 C
Volume of 1 m Volume of 1 M













Data from ISCO (1982).
Dilute the combined 1 m  stock solution to 1000 ml with distilled H20. pH is 
calculated according to the Henderson-Hasselbalch equation:
pH = pK' + log 
where pK' = 6.86 at 25°C.
(proton acceptor) 
proton donor
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An assessment of radioimmunoassay procedures 
for determination of anti-acetylcholine receptor 
antibodies in the sera of patients with myasthenia 
gravis
B CARTER,  R H A R R I S O N ,  G G L U N T ,  H MORRIS ,
T S A V A G E - M A R E N G O ,  A N D  F A S T E P H E NS ON
From the Department o f Biochemistry, University o f Bath, Claverton Down, Bath BA2 7A Y
s u m m a r y  A reproducible radioimmunoassay procedure for the determination of anti-acetylcholine 
receptor antibodies in the sera of patients with myasthenia gravis is described and examined in 
detail. The assay combines features of a number of methods previously outlined and allows repeat 
determinations of antibody titre in a given myasthenic serum sample with coefficient of variation 
6 %. The mean ±  standard deviation for normal human serum anti-acetylcholine receptor antibodies 
was found by this procedure to be 0-024 ±  0-033 nmol/1 a-bungarotoxin binding sites whereas the 
range for myasthenic patients was 0-139-14 nmol /I with a mean value of 7 • 55 nmol /I a-bungarotoxin 
binding sites.
Myasthenia gravis is generally recognised to be an 
autoimmune disease in which patients develop an 
immune response to self nicotinic acetylcholine 
receptor (AChR) at the neuromuscular junction.1 
Approximately 90% of myasthenia patients show 
elevated serum levels of anti-AChR antibodies,2 and 
there is an increasing demand for determination of 
such levels as an aid to diagnosis. Despite the usual 
presence of anti-AChR antibodies in the sera of 
myasthenia gravis patients, correlation of antibody 
titre with severity of symptoms is generally poor 
between patients.3-5 Nevertheless, titres followed for 
a given patient over a period of time can reflect the 
clinical state of the patient, and serial assays can be 
used to monitor the effects of particular treatment 
regimens.6
A  basic radioimmunoassay for the determination 
of anti-AChR antibody titres in human sera has 
been reported by a number of groups of workers.3 7-10 
The assay involves specific labelling of human AChR  
with radiolabelled snake venom a-toxin followed 
by the use of the labelled AChR, in excess, to 
precipitate anti-AChR antibodies present in the 
patient’s serum. The assay is relatively complex, and 
a number of aspects of the published procedures 
differ widely, depending upon the authors. In  many 
cases, moreover, exact experimental details are 
unclear, and the reasons underlying the choice of a
particular technique or set of conditions are un­
specified. We now report an examination of a 
number of variable factors in the radioimmuno­
assay, the results of which lead to an overall method 
suitable for routine application.
Material and methods
Myasthenic and normal human sera were quickly 
frozen and stored at — 20°C before assay. Human 
muscle was obtained from lower limb amputations. 
Within 15 minutes of amputation, calf muscle was 
crudely dissected free from fat, tendon, and skin, 
transported in ice or solid carbon dioxide (approx. 
20 minutes), and stored at — 80°C.
a-Bungarotoxin from Bungarus multicinctus was 
purchased from Boehringer, Mannheim, West 
Germany as a lyophilised powder (1 mg), which 
was dissolved in 0-05 mol/1 potassium phosphate 
buffer, pH  7-5 (2 ml), and stored at — 20°C before 
use. Na 125I  in dilute NaO H solution (100 mCi/ml) 
was supplied by the Radiochemical Centre, Amer- 
sham, U K , and benzoquinonium chloride was a 
generous gift from Stirling Winthrop Inc, Rensse­
laer, N Y , USA. All other chemicals were from 
Sigma Chemical Co, Kingston upon Thames, UK, 
or from B D H  Chemicals, Poole, Dorset, U K.
125I-Labelled a-bungarotoxin was prepared
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T S A V A G E - M A R E N G O ,  A N D  F A S T E P H E N S O N
From the Department o f Biochemistry, University o f  Bath, Claverton Down, Bath BA2 7A Y
summary A reproducible radioimmunoassay procedure for the determination o f anti-acetylcl 
receptor antibodies in the sera o f patients with myasthenia gravis is described and examir 
detail. The assay combines features of a number o f methods previously outlined and allows i 
determinations of antibody titre in a given myasthenic serum sample with coefficient o f var 
6 %. The mean ±  standard deviation for normal human serum anti-acetylcholine receptor antit 
was found by this procedure to be 0-024 ±  0-033 nmol/1 a-bungarotoxin binding sites where 
range for myasthenic patients was 0-139-14 nmol/1 with a mean value of 7-55 nmol/1 a-bungarc 
binding sites.
Myasthenia gravis is generally recognised to be an 
autoimmune disease in which patients develop an 
immune response to self nicotinic acetylcholine 
receptor (AChR) at the neuromuscular junction.1 
Approximately 90% of myasthenia patients show 
elevated serum levels of anti-AChR antibodies,2 and 
there is an increasing demand for determination of 
such levels as an aid to diagnosis. Despite the usual 
presence of anti-AChR antibodies in the sera of 
myasthenia gravis patients, correlation of antibody 
titre with severity of symptoms is generally poor 
between patients.3-5 Nevertheless, titres followed for 
a given patient over a period of time can reflect the 
clinical state of the patient, and serial assays can be 
used to monitor the effects of particular treatment 
regimens.6
A basic radioimmunoassay for the determination 
of anti-AChR antibody titres in human sera has 
been reported by a number of groups of workers.3 7-10 
The assay involves specific labelling of human AChR  
with radiolabelled snake venom a-toxin followed 
by the use of the labelled AChR, in excess, to 
precipitate anti-AChR antibodies present in the 
patient’s serum. The assay is relatively complex, and 
a number of aspects of the published procedures 
differ widely, depending upon the authors. In many 
cases, moreover, exact experimental details are 
unclear, and the reasons underlying the choice of a
particular technique or set of conditions ai 
specified. We now report an examination 
number of variable factors in the radioinu 
assay, the results of which lead to an overall ir 
suitable for routine application.
Material and methods
Myasthenic and normal human sera were q 
frozen and stored at — 20°C before assay. E 
muscle was obtained from lower limb amput; 
Within 15 minutes of amputation, calf muse 
crudely dissected free from fat, tendon, and 
transported in ice or solid carbon dioxide (a] 
20 minutes), and stored at — 80°C.
a-Bungarotoxin from Bungarus multicincti 
purchased from Boehringer, Mannheim, 
Germany as a lyophilised powder (1 mg), 
was dissolved in 0-05 mol/I potassium pho: 
buffer, pH 7-5 (2 ml), and stored at — 20°C 
use. Na 125I  in dilute NaOH solution (100 m< 
was supplied by the Radiochemical Centre, . 
sham, U K , and benzoquinonium chloride 
generous gift from Stirling Winthrop Inc, R 
laer, N Y , USA. All other chemicals were 
Sigma Chemical Co, Kingston upon Thames 
or from BDH Chemicals, Poole, Dorset, UK.
125I-Labelled a-bungarotoxin was pre
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hours at 22°C). The resulting precipitate was 
separated by centrifugation at 3000 g for 10 minutes, 
and the pellet was washed twice with 0-01 mol/1 
potassium phosphate buffer, pH 7-5, containing
0-15 mol/1 NaCl, 1 % (v/v) Triton X-100, and 0-1 % 
(w/v) N aN 3 and counted for radioactivity. Specific 
binding of a-toxin was blocked in parallel incubations 
performed as above but containing additionally
1-0 mmol/1 benzoquinonium chloride (or 0-1 
mmol/1 d-tubocurarine or 0 1  mmol/1 non-radio­
active bungarotoxin). Subtraction of the counts so 
obtained gave specifically-bound radioactivity in the 
test sample, which can then be related to the concen­
tration of a-bungarotoxin-binding sites in the AChR  
extract. Thus the antibody titre is expressed as moles 
of specific a-bungarotoxin binding sites precipitated 
per litre of serum.
Maximal formation of AChR-antibody complexes 
was routinely checked by repeating the assay using 
serial twofold dilutions (with normal human sera) 
of antisera in order to ensure a linear relation 
between the volume of undiluted serum and pre­
cipitated radioactivity.
Results and discussion
The concentration of soluble AChR in the primary 
detergent extracts of human muscle was found to 
vary from 0-1 to 2-5 nmol /I a-bungarotoxin- 
binding sites over 20 preparations with a mean value 
of 0-52 nmol/1 toxin-binding sites. This represents a 
mean recovery of 0-49 pmol toxin-binding sites per 
gram muscle.
The wide variation in a-bungarotoxin-binding 
activities of different muscle samples may reflect 
differences in the clinical state of the muscle samples 
before amputation. Muscle was always obtained 
from legs amputated because of either vascular 
disorders or diabetic gangrene, and it is possible 
that the different samples had been subjected to 
varying periods of ischaemia with attendant partial 
autolysis. Moreover most amputees were patients 
over 60 years of age who are known14 to be subject 
to significant and varying degrees of motor de- 
nervation. This raises the further possibility of 
variable extents of acetylcholine receptor prolifer­
ation15 in the muscle samples we examined, al­
though this was not reflected in binding studies 
carried out by us on purified receptor preparations.16
Attempts to prepare useful extracts of acetylcho­
line receptor from postmortem muscle proved to be 
generally unsatisfactory, giving receptor concen­
trations of less than 0-1 nmol /I toxin binding sites. 
This probably reflects the occurrence of autolysis 
during the extended periods (more than 6 hours) 
elapsing between death and freezing of the muscle.
With regard to the method of extraction of AChR, 
the inclusion in the buffers of phenylmethylsulphonyl 
fluoride and benzethonium chloride as anti-proteo­
lytic agents was found generally to improve the 
yield of AChR. Similar yields of AChR were found 
whether extraction in Triton-containing buffer was 
carried out for 16 hours at 4°C or for 3 hours at 
20 °C.
The concentration of AChR extract (0-5 nmol/1) 
recommended in the Methods section for use in the 
radioimmunoassay of anti-AChR antibody titres is 
only slightly less than the mean value in the extracts. 
This inevitably means that many preparations 
contain concentrations of receptor suboptimal for 
this purpose, and re-extraction of the muscle 
homogenate (Methods section) was found to give 
secondary extracts whh 46 ± 3 3 %  ( ±  SD, 6 
preparations) of the toxin-binding activity of the 
primary extract. Such re-extraction was often 
worthwhile in the case of relatively high-activity 
receptor preparations in order to supplement stocks 
of useful receptor.
Storage of AChR extracts at 4°C for periods of up 
to three months led to less than 40% loss of toxin- 
binding activity.
In  the determination of AChR concentration, 
pre-incubation of AChR with 125I-labelled a- 
bungarotoxin for periods of longer than 15 minutes, 
up to 5 hours, was found’not to affect the results. 
On the other hand, incubation of the AChR-toxin 
complex with (N H 4)2S 04 for less than 16 hours led 
to diminished precipitation of radioactivity.
Separation of AChR-toxin complex from free 
toxin can be effected alternatively by filtration 
through D EAE cellulose filter discs on a Millipore 
filtration system10 followed by washing the discs with 
0-01 mol/1 potassium phosphate buffer, pH 7-5, 
containing 0-1% (w/v) bovine serum albumin,
0-01% (w/v) N a N ?, and 1-0% (v/v) Triton X-100. 
In  our hands, specifically-bound radioactive counts 
were consistently found to be 60-85% lower than 
those obtained by using (N H 4)2S 04 precipitation, a 
decrease that is at least partially attributable to 
saturation of the filters by the high levels of protein 
in the extract.917 These levels can be reduced by 
dilution of the extract before filtration, which can 
lead, however, to unacceptable loss of sensitivity in 
the case of lower activity extracts. The D EA E filter 
assay is, nevertheless, much faster than that based 
on (N H 4)2S 04 precipitation and can be used to give 
rapid estimates of AChR concentration for use in 
the radioimmunoassay of anti-AChR antibodies.
A third method of separation of AChR-toxin 
complexes from free toxin in the routine assay of 
AChR concentrations involves the addition of 
excess myasthenic serum followed by goat
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hours at 22°C). The resulting precipitate was 
separated by centrifugation at 3000 g for 10 minutes, 
and the pellet was washed twice with 0-01 mol/I 
potassium phosphate buffer, pH 7-5, containing
0-15 mol/1 NaCl, 1 % (v/v) Triton X-100, and 0-1 % 
(w/v) N aN 3 and counted for radioactivity. Specific 
binding of a-toxin was blocked in parallel incubations 
performed as above but containing additionally
1-0 mmol/1 benzoquinonium chloride (or 0-1 
mmol/I d-tubocurarine or 0 1  mmol /I non-radio- 
active bungarotoxin). Subtraction of the counts so 
obtained gave specifically-bound radioactivity in the 
test sample, which can then be related to the concen­
tration of a-bungarotoxin-binding sites in the AChR  
extract. Thus the antibody titre is expressed as moles 
of specific a-bungarotoxin binding sites precipitated 
per litre of serum.
Maximal formation of AChR-antibody complexes 
was routinely checked by repeating the assay using 
serial twofold dilutions (with normal human sera) 
of antisera in order to ensure a linear relation 
between the volume of undiluted serum and pre­
cipitated radioactivity.
Results and discussion
The concentration of soluble AChR in the primary 
detergent extracts of human muscle was found to 
vary from 0-1 to 2-5 nmol/1 a-bungarotoxin- 
binding sites over 20 preparations with a mean value 
of 0-52 nmol/I toxin-binding sites. This represents a 
mean recovery of 0-49 pmol toxin-binding sites per 
gram muscle.
The wide variation in a-bungarotoxin-binding 
activities of different muscle samples may reflect 
differences in the clinical state of the muscle samples 
before amputation. Muscle was always obtained 
from legs amputated because of either vascular 
disorders or diabetic gangrene, and it is possible 
that the different samples had been subjected to 
varying periods of ischaemia with attendant partial 
autolysis. Moreover most amputees were patients 
over 60 years of age who are known14 to be subject 
to significant and varying degrees of motor de- 
nervation. This raises the further possibility of 
variable extents of acetylcholine receptor prolifer­
ation15 in the muscle samples we examined, al­
though this was not reflected in binding studies 
carried out by us on purified receptor preparations.16
Attempts to prepare useful extracts of acetylcho­
line receptor from postmortem muscle proved to be 
generally unsatisfactory, giving receptor concen­
trations of less than 0-1 nmol/1 toxin binding sites. 
This probably reflects the occurrence of autolysis 
during the extended periods (more than 6 hours) 
elapsing between death and freezing of the muscle.
With regard to the method of extraction of AC 
the inclusion in the buffers of phenylmethylsulph 
fluoride and benzethonium chloride as anti-prc 
lytic agents was found generally to improve 
yield of AChR. Similar yields of AChR were fc 
whether extraction in Triton-containing buffer 
carried out for 16 hours at 4°C or for 3 houi 
20°C.
The concentration of AChR extract (0-5 nm 
recommended in the Methods section for use ir 
radioimmunoassay of anti-AChR antibody titr< 
only slightly less than the mean value in the extr 
This inevitably means that many preparal 
contain concentrations of receptor suboptimal 
this purpose, and re-extraction of the mi 
homogenate (Methods section) was found to 
secondary extracts wifh 46 ±  33% ( ±  SE 
preparations) of the toxin-binding activity of 
primary extract. Such re-extraction was ( 
worthwhile in the case of relatively high-acl 
receptor preparations in order to supplement st 
of useful receptor.
Storage of AChR extracts at 4°C for periods < 
to three months led to less than 40% loss of ti 
binding activity.
In the determination of AChR concentra 
pre-incubation of AChR with 125I-labellec 
bungarotoxin for periods of longer than 15 mir 
up to 5 hours, was found' not to affect the rei 
On the other hand, incubation of the AChR- 
complex with (N H 4)2S 04 for less than 16 hour 
to diminished precipitation of radioactivity.
Separation of AChR-toxin complex from 
toxin can be effected alternatively by filtr 
through D EA E cellulose filter discs on a M ill 
filtration system10 followed by washing the discs 
0-01 mol/1 potassium phosphate buffer, pH  
containing 0-1% (w/v) bovine serum albi 
0-01% (w/v) NaNg, and 1-0% (v/v) Triton X 
In  our hands, specifically-bound radioactive o 
were consistently found to be 60-85% lower 
those obtained by using (N H 4)2S 04 precipitati 
decrease that is at least partially attributab 
saturation of the filters by the high levels of pr 
in the extract.917 These levels can be reduct 
dilution of the extract before filtration, whicl 
lead, however, to unacceptable loss of sensitiv 
the case of lower activity extracts. The DEAE  
assay is, nevertheless, much faster than that 
on (N H 4)2S 04 precipitation and can be used t< 
rapid estimates of AChR concentration for i 
the radioimmunoassay of anti-AChR antibod
A  third method of separation of AChR  
complexes from free toxin in the routine ass 
AChR concentrations involves the additic 
excess myasthenic serum followed by
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alternatively by incubation for 1, 2, o r 4 hours at 
22 °C.
As described in the  M ethods section, serial 
dilutions o f m yasthenic sera were m ade routinely in 
order to  ensure tha t the antibody assay was being 
done w ith sufficient m olar excess o f labelled A C hR . 
A n exam ination o f the  dependence o f apparen t 
antibody titres on the m olar ratio  o f labelled A C hR  
to  specific antibodies showed th a t m olar ratios of 
approxim ately 3:1 were sufficient to  ensure maximal 
precipitation o f anti-A C hR  antibodies in the 
myasthenic samples tested (Fig. 2). M aximal 
form ation o f A C hR -anti-A C hR  antibody complexes 
requires no t only a m inim um  A C hR -antibody ratio  
but also a m inim um  concentration o f  A C hR , which 
in tu rn  depends upon the dissociation constants of 
the  A C hR -antibody complexes. A study o f three 
myasthenic sera showed (Fig. 3) th a t m inim al 
concentrations o f A C hR  of 0 -3 -0 -5  nmol/1, 
depending on the  serum  sample, were sufficient to  
effect m axim um  form ation o f complex. This range 
is just below the  level 0-5 nmol/1 o f A C hR  con­
centration  suggested for use in the radioim m uno­
assay. Nevertheless the results indicate th a t the 
la tter value m ay be close to  a m inim um  acceptable 
figure for som e m yasthenic sera and  th a t higher 
concentrations o f receptor, if they can be obtained, 
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Fig. 2 Formation o f  AChR-anti-AChR antibody com­
plexes at varying molar ratios o f  toxin-labelled AChR to 
antibody. A single appropriate dilution o f  serum was made 
from  each o f  three different myasthenic patients. Samples 
(5 \J.l) o f  each were incubated with increasing amounts o f  a 
fixed  concentration o f  toxin-labelled AChR, and labelled 
AChR-antibody complexes were precipitated and counted 
as described fo r  the antibody assay procedure (see text). 
The molar concentrations o f  antibody were, in each case, 
obtained from  the maximum amount o f  AChR precipitated. 
Concentrations o f  toxin-labelled AChR were m, 1-02 
nmol/1, A, 1-32 nmol 11, and O, 0-32 nmol/I.
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Fig. 3 Formation o f  AChR-anti-AChR antibody com­
plexes by varying concentrations o f  toxin-labelled AChR. 
A single appropriate dilution o f  serum was made from  each 
o f  three different myasthenic patients. Samples (5 \j.I) o f  
each were incubated with a constant amount o f toxin- 
labelled AChR at different concentrations so that a constant 
molar ratio o f  toxin-labelled AChR: anti-AChR anti­
bodies was maintained. These ratios were •  , 3:1; A, 7:1; 
0 ,1 0 :1 . Labelled AChR-antibody complexes were pre­
cipitated and counted as described fo r  the antibody assay 
procedure (see text).
The procedure for radioim m unoassay o f anti- 
A C hR  antibodies outlined in the  M ethods section 
allows the determ ination o f relatively reproducible 
titres. Thus, repeat determ inations on an individual 
serum  sample using a single extract o f acetylcholine 
receptor and a single freshly prepared sample 
of 125I-labelled a-bungarotoxin  gave values of
2-99 ±  0-17 ( ±  SD, 15 assays) nmol/1 a-bungaro- 
toxin binding sites. R epeat assays o f the same serum  
using a single extract o f acetylcholine receptor and 
four different preparations o f 125I-labelled a- 
bungarotoxin gave values o f 3-23 ±  0-31 ( ±  SD) 
nmol/1 a-bungarotoxin binding sites (where the 
mean value for each toxin preparation  resulted from
15 separate assays). R epeat assays o f a different 
serum  sample using a single preparation o f 125I- 
labelled a-bungarotoxin and four different extracts 
o f acetylcholine receptor gave values o f 1 -80 ±  0-22 
( ±  SD) nmol/1 a-bungarotoxin  binding sites (where 
the mean value for each extract o f acetylcholine 
receptor resulted from  10 separate assays).
It can be seen th a t ra ther m ore variability in these 
assays is usually found when different 125I-labelled 
a-bungarotoxin and  acetylcholine receptor p repara­
tions are used. T itres obtained for a given serum 
sample using a single extract o f acetylcholine 
receptor and sam ple o f labelled toxin change little 
over a period o f less th an  three weeks. Thus repeat 
assays o f a single serum  sam ple using one extract o f 
acetylcholine receptor m ade using freshly 125I- 
labelled a-bungarotoxin  and the same toxin after
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alternatively by incubation for 1, 2, or 4 hours at 
22°C.
As described in the Methods section, serial 
dilutions of myasthenic sera were made routinely in 
order to ensure that the antibody assay was being 
done with sufficient molar excess of labelled AChR. 
An examination of the dependence of apparent 
antibody titres on the molar ratio of labelled AChR  
to specific antibodies showed that molar ratios of 
approximately 3:1 were sufficient to ensure maximal 
precipitation of anti-AChR antibodies in the 
myasthenic samples tested (Fig. 2). Maximal 
formation of AChR-anti-AChR antibody complexes 
requires not only a minimum AChR-antibody ratio 
but also a minimum concentration of AChR, which 
in turn depends upon the dissociation constants of 
the AChR-antibody complexes. A  study of three 
myasthenic sera showed (Fig. 3) that minimal 
concentrations of AChR of 0-3-0 -5 nmol/1, 
depending on the serum sample, were sufficient to 
effect maximum formation of complex. This range 
is just below the level 0-5 nmol/1 of AChR con­
centration suggested for use in the radioimmuno­
assay. Nevertheless the results indicate that the 
latter value may be close to a minimum acceptable 
figure for some myasthenic sera and that higher 
concentrations of receptor, if they can be obtained, 
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F ig . 2 Formation o f  AChR-anti-AChR antibody com­
plexes at varying molar ratios o f  toxin-labelled AChR to 
antibody. A single appropriate dilution o f  serum was made 
from  each o f  three different myasthenic patients. Samples 
(5  |x/) o f  each were incubated with increasing amounts o f  a 
fixed  concentration o f  toxin-labelled AChR, and labelled 
AChR-antibody complexes were precipitated and counted 
as described fo r  the antibody assay procedure (see text). 
The molar concentrations o f  antibody were, in each case, 
obtained from  the maximum amount o f  AChR precipitated. 
Concentrations o f  toxin-labelled AChR were m, 1-02 
nmol/l, A, 1’ 32 nmol/l, andO , 0-32 nmol/I.
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F ig . 3 Formation o f  AChR-anti-AChR antibody a  
plexes by varying concentrations o f  toxin-labelled AC  
A single appropriate dilution o f  serum was made from  e 
o f  three different myasthenic patients. Samples (5  |il]  
each were incubated with a constant amount o f  to; 
labelled AChR at different concentrations so that a const 
molar ratio o f  toxin-labelled AChR: anti-AChR a 
bodies was maintained. These ratios were • ,  3:1 ; A, / 
0 ,10:1. Labelled AChR-antibody complexes were /  
cipitated and counted as described fo r  the antibody as 
procedure (see text).
The procedure for radioimmunoassay of ai 
AChR antibodies outlined in the Methods secti 
allows the determination of relatively reproduci 
titres. Thus, repeat determinations on an individi 
serum sample using a single extract of acetylcholi 
receptor and a single freshly prepared sam 
of 125I-labelled a-bungarotoxin gave values
2-99 ±  0-17 ( ±  SD, 15 assays) nmol/l a-bungai 
toxin binding sites. Repeat assays of the same sen 
using a single extract of acetylcholine receptor a 
four different preparations of 125I-labelled 
bungarotoxin gave values of 3-23 ±  0-31 ( ±  SI 
nmol/l a-bungarotoxin binding sites (where t 
mean value for each toxin preparation resulted frc 
15 separate assays). Repeat assays of a differe 
serum sample using a single preparation of 12 
labelled a-bungarotoxin and four different extrai 
of acetylcholine receptor gave values of 1 -80 ±  0- 
( ±  SD) nmol/l a-bungarotoxin binding sites (whe 
the mean value for each extract of acetylcholi 
receptor resulted from 10 separate assays).
It can be seen that rather more variability in the 
assays is usually found when different 125I-labell< 
a-bungarotoxin and acetylcholine receptor prepar 
tions are used. Titres obtained for a given seru 
sample using a single extract of acetylcholii 
receptor and sample of labelled toxin change litl 
over a period of less than three weeks. Thus repe 
assays of a single serum sample using one extract i 
acetylcholine receptor made using freshly 125 
labelled a-bungarotoxin and the same toxin aft
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